Anxiety disorders

KRA_PSY_ANXIETY

anxiety disorder: A category of psychiatric disorders which are characterized by anxious feelings or fear often accompanied by physical symptoms associated with anxiety.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F40-F48 Hospital discharge: ICD-9 — 300[0-3\|6-9]\|3078A\|309 Hospital discharge: ICD-8 — 300[0-2]\|30030\|300[5-9]\|305\|30680\|30799 Cause of death: ICD-10 — F40-F48 Cause of death: ICD-9 — 300[0-3\|6-9]\|3078A\|309 Cause of death: ICD-8 — 300[0-2]\|30030\|300[5-9]\|305\|30680\|30799 2 out of 7 registries used, show all original rules.	59081
4. Check minimum number of events None	59081
5. Include endpoints None	59081
6. Filter based on genotype QC (FinnGen only)	59081

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	KRA_PSY_ANXIETY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F4
HD_ICD_9	300[0-3\|6-9]\|3078A\|309
HD_ICD_8	300[0-2]\|30030\|300[5-9]\|305\|30680\|30799
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F4
COD_ICD_9	300[0-3\|6-9]\|3078A\|309
COD_ICD_8	300[0-2]\|30030\|300[5-9]\|305\|30680\|30799
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Anxiety disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	59081	40895	18186
Unadjusted period prevalence (%)	12.12	13.94	8.02
Median age at first event (years)	36.61	36.04	37.91

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
35650: Matched controls
283303

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F41.1

ICD-10 Finland

Generalized anxiety disorder

30.2

323.0

4294

1278

F43.1

ICD-10 Finland

Post-traumatic stress disorder

32.1

323.0

1717

446

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

6.5

323.0

5478

7699

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

10.1

323.0

860

695

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

9.2

323.0

1413

1271

M54.5

ICD-10 Finland

Low back pain

1.9

323.0

11811

58648

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

12.1

323.0

3968

2906

K02.1

ICD-10 Finland

Caries of dentine

1.7

323.0

19619

119303

F32

ICD-10 Finland

Depressive episode

4.2

323.0

2378

4759

F45.8

ICD-10 Finland

Other somatoform disorders

4.9

323.0

3558

6215

F61.0

ICD-10 Finland

Mixed personality disorders

18.2

323.0

1493

677

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

60.9

323.0

933

125

30799

ICD-8 Finland

Transient situational disturbances

+∞

323.0

359

30088

ICD-8 Finland

Neuroses, Other

+∞

323.0

565

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

8.8

323.0

831

769

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

23.0

323.0

1150

409

N06AG02

ATC

moclobemide; oral

5.0

323.0

2583

4335

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.7

323.0

3237

10192

N06AA12

ATC

doxepin; systemic

4.6

323.0

2923

5389

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

11.5

323.0

1381

989

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

323.0

13694

80177

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

6.4

323.0

2473

3248

A04

ICPC

Weakness/tiredness general

2.3

323.0

4106

15045

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

60.0

323.0

1503

208

F43.2

ICD-10 Finland

Adjustment disorders

9.4

323.0

861

740

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

7.4

323.0

1113

1223

F34.1

ICD-10 Finland

Dysthymia

10.4

323.0

2654

2182

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

323.0

13966

81361

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

11.0

323.0

1451

1093

N06AX03

ATC

mianserin; oral

5.4

323.0

2870

4513

P76

ICPC

Depressive disorder

5.8

323.0

3464

5170

F41.3

ICD-10 Finland

Other mixed anxiety disorders

21.5

323.0

806

305

N04AA02

ATC

biperiden; systemic

5.5

323.0

1070

1571

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

+∞

323.0

469

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

+∞

323.0

488

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

20.3

323.0

650

259

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

11.9

323.0

768

521

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.0

323.0

1011

1364

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

9.8

323.0

1211

1010

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.0

323.0

1001

1363

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

+∞

323.0

1041

F51.0

ICD-10 Finland

Nonorganic insomnia

3.1

323.0

5763

16725

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

12.6

323.0

1754

1160

M79.6

ICD-10 Finland

Pain in limb

1.8

323.0

12333

64674

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

36.9

323.0

1722

389

N07BB01

ATC

disulfiram; oral

5.0

323.0

2755

4645

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

323.0

24521

157606

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

323.0

13813

77174

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

9.2

323.0

2056

1881

F60.9

ICD-10 Finland

Personality disorder, unspecified

19.6

323.0

1076

448

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

8.8

323.0

1729

1625

R51.80

ICD-10 Finland

Headache

2.5

323.0

5606

19815

F43.29

ICD-10 Finland

Adaptation disorder UNS

28.5

323.0

1933

568

F39

ICD-10 Finland

Unspecified mood [affective] disorder

9.7

323.0

939

788

N06AX22

ATC

agomelatine; oral

7.9

323.0

1225

1267

N05AF03

ATC

chlorprothixene; systemic

7.8

323.0

1897

2019

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

9.9

323.0

1106

911

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

115.9

323.0

461

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

13.6

323.0

716

426

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

323.0

7253

35088

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

10.0

323.0

5366

4908

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

12.2

323.0

964

642

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

11.8

323.0

1518

1065

N05AF01

ATC

flupentixol; systemic

6.9

323.0

969

1145

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

323.0

4511

14776

T36

ICD-10 Finland

Poisoning by systemic antibiotics

9.2

323.0

3298

3096

G44.2

ICD-10 Finland

Tension-type headache

2.3

323.0

4854

18054

N05BE01

ATC

buspirone; oral

10.2

323.0

2287

1886

N06AB06

ATC

sertraline; oral

5.9

323.0

7150

11588

EBA00

NOMESCO Finland

Extraction of tooth

1.7

323.0

10862

58292

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

7.1

323.0

1626

1903

R53

ICD-10 Finland

Malaise and fatigue

2.4

323.0

7501

28208

L03

ICPC

Low back symptom/complaint

1.8

323.0

7940

38318

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

6.9

323.0

1457

1743

P99

ICPC

Psychological disorders other

6.9

323.0

1551

1867

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

12.7

323.0

3131

2133

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

19.0

323.0

7466

3887

WX290

NOMESCO Finland

Other blockade of nerve

1.7

323.0

15060

86733

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

323.0

5513

23800

N06AX05

ATC

trazodone; oral

7.2

323.0

1513

1735

N05AX08

ATC

risperidone; systemic

5.2

323.0

4342

7333

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

12.1

323.0

856

576

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

8.6

323.0

6133

6653

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

101.7

323.0

405

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.0

323.0

6328

7472

F41.00

ICD-10 Finland

Moderate panic disorder

156.6

323.0

1529

F43.01

ICD-10 Finland

Acute stress reaction moderate

10.2

323.0

871

697

F41.8

ICD-10 Finland

Other specified anxiety disorders

13.2

323.0

1559

975

R42

ICD-10 Finland

Dizziness and giddiness

1.9

323.0

7056

32111

N06AB08

ATC

fluvoxamine; oral

5.7

323.0

1629

2379

N06AA06

ATC

trimipramine; systemic

5.2

323.0

1314

2084

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

11.5

323.0

1234

878

N06AB05

ATC

paroxetine; oral

5.7

323.0

4047

6197

N06AA09

ATC

amitriptyline; systemic

3.3

323.0

4848

12905

N05BA01

ATC

diazepam; systemic, rectal

4.4

323.0

7872

17290

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

12.0

323.0

1662

1150

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

10.2

323.0

729

579

F45.0

ICD-10 Finland

Somatization disorder

76.9

323.0

449

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

80.2

323.0

478

N05AB03

ATC

perphenazine; systemic, rectal

6.7

323.0

2364

2975

N03AE01

ATC

clonazepam; systemic

5.3

323.0

3574

5796

F40.2

ICD-10 Finland

Specific (isolated) phobias

37.8

323.0

479

102

F40.1

ICD-10 Finland

Social phobias

49.2

323.0

2072

355

N05AN01

ATC

lithium; oral

6.9

323.0

1488

1780

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

323.0

10919

59491

F29

ICD-10 Finland

Unspecified nonorganic psychosis

7.3

323.0

2473

2877

SPAT1254

SPAT

Administration of medicine

2.1

323.0

4570

18947

N05CF02

ATC

zolpidem; oral

2.5

323.0

7561

27950

N03AG01

ATC

valproic acid; systemic, rectal

5.1

323.0

3623

6117

A02BC01

ATC

omeprazole; systemic

1.8

323.0

9025

45615

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

10.0

323.0

958

778

C07AA05

ATC

propranolol; systemic

3.1

323.0

9137

28620

N05BA12

ATC

alprazolam; oral

5.1

323.0

6601

12193

P03

ICPC

Feeling depressed

4.7

323.0

4348

8085

P06

ICPC

Sleep disturbance

2.6

323.0

3730

12244

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.2

323.0

4842

13297

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

12.0

323.0

1428

979

P01

ICPC

Feeling anxious/nervous/tense

5.8

323.0

5114

7889

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.0

323.0

1145

1852

WX110

NOMESCO Finland

Local anesthesy

1.7

323.0

23655

152711

N05AD01

ATC

haloperidol; systemic

4.4

323.0

1313

2419

AA1AD

NOMESCO Finland

CT of head and brain

1.9

323.0

7826

36345

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

323.0

9924

49424

N05BA02

ATC

chlordiazepoxide; systemic

5.6

323.0

1351

1992

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

323.0

6679

30146

Z71.8

ICD-10 Finland

Other specified counselling

2.0

323.0

8076

36823

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

323.0

9460

45062

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

323.0

17778

110006

N06AB04

ATC

citalopram; systemic

5.0

323.0

13300

30381

F43.00

ICD-10 Finland

Acute stress reaction mild

10.8

323.0

1643

1264

N06AX26

ATC

vortioxetine; oral

5.4

323.0

3144

4939

N05BA04

ATC

oxazepam; oral

5.1

323.0

14751

34626

R03AC02

ATC

salbutamol; inhalant

1.6

323.0

17721

106912

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

10.2

323.0

1433

1163

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

25.8

323.0

4163

1446

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

323.0

9984

48301

N03AF01

ATC

carbamazepine; oral, rectal

3.1

323.0

2077

5589

N05BA06

ATC

lorazepam; systemic, sublingual

5.2

323.0

2803

4589

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

12.1

323.0

1127

760

N06AX16

ATC

venlafaxine; oral

6.1

323.0

9699

16461

P29

ICPC

Psychological sympt/compl other

5.5

323.0

2944

4550

P74

ICPC

Anxiety disorder/anxiety state

9.2

323.0

2085

1897

N05AX12

ATC

aripiprazole; systemic

7.8

323.0

2483

2685

N05AH04

ATC

quetiapine; oral

7.4

323.0

12092

18366

N03AX16

ATC

pregabalin; oral

2.6

323.0

10289

38444

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

323.0

16753

98617

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

10.7

323.0

875

664

N06AA04

ATC

clomipramine; systemic

8.5

323.0

1192

1145

N05AA02

ATC

levomepromazine; systemic

8.0

323.0

3068

3304

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

11.9

323.0

4372

3300

F31.8

ICD-10 Finland

Other bipolar affective disorders

9.9

323.0

1093

905

N05AH02

ATC

clozapine; systemic

5.7

323.0

1103

1581

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

24.1

323.0

950

321

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

89.3

323.0

433

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.8

323.0

3907

7102

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

323.0

5545

23810

SPAT1307

SPAT

Psychosocial counselling and guidance

4.4

323.0

2246

4259

SPAT1240

SPAT

Therapeutic discussion

4.2

323.0

5208

11029

F41.01

ICD-10 Finland

Severe panic disorder

114.4

323.0

427

IGY99

NOMESCO Finland

Other psychiatric treatment contact

12.4

323.0

1069

702

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

11.6

323.0

1414

1006

A02BC03

ATC

lansoprazole; oral

1.7

323.0

9902

52154

F32.9

ICD-10 Finland

Depressive episode, unspecified

8.2

323.0

9243

11593

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

11.5

323.0

681

479

N03AX12

ATC

gabapentin; oral

2.6

323.0

6546

22668

A02BC05

ATC

esomeprazole; systemic

1.7

323.0

13938

79064

N02BE01

ATC

paracetamol; systemic, rectal

1.7

323.0

29090

203953

N06AX11

ATC

mirtazapine; oral

4.3

323.0

17508

51432

P15

ICPC

Chronic alcohol abuse

4.6

323.0

1471

2613

F99

ICD-10 Finland

Mental disorder, not otherwise specified

8.9

323.0

1254

1157

F32.1

ICD-10 Finland

Moderate depressive episode

5.0

323.0

2696

4556

IGY02

NOMESCO Finland

Psychiatric monitoring contact

10.9

323.0

1358

1028

F10.20

ICD-10 Finland

Alcohol dependence currently independent

8.3

323.0

1455

1442

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

323.0

12996

60320

A02BA02

ATC

ranitidine; systemic

1.9

323.0

6623

30811

N06AX12

ATC

bupropion; oral

6.4

323.0

3872

5262

N05CD07

ATC

temazepam; oral

3.7

323.0

6049

14885

N06AB03

ATC

fluoxetine; oral

4.6

323.0

7534

15592

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

7.2

323.0

1034

1173

F43.8

ICD-10 Finland

Other reactions to severe stress

7.9

323.0

1088

1120

N05CF01

ATC

zopiclone; oral

2.9

323.0

14433

53257

N02AX02

ATC

tramadol; systemic, rectal

1.8

323.0

14968

81142

N06AB10

ATC

escitalopram; oral

4.6

323.0

11573

26914

N06AX21

ATC

duloxetine; oral

4.5

323.0

6424

13207

R52.2

ICD-10 Finland

Other chronic pain

4.1

323.0

1520

3016

A06AD11

ATC

lactulose; oral

2.3

323.0

4683

17516

A02BC02

ATC

pantoprazole; systemic

1.8

323.0

22720

138461

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

323.0

19285

117666

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

323.0

8082

39725

N05AH03

ATC

olanzapine; systemic

7.9

323.0

4556

5139

N03AX09

ATC

lamotrigine; oral

7.3

323.0

3000

3525

R06.0

ICD-10 Finland

Dyspnoea

1.9

323.0

8208

38003

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.8

323.0

2958

8868

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

24.4

323.0

8311

3493

F41.09

ICD-10 Finland

UNS Panic Syndrome

29.0

323.0

2421

711

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

10.1

323.0

2581

2176

M79.1

ICD-10 Finland

Myalgia

2.1

322.7

4350

17717

A01

ICPC

Pain general/multiple sites

2.6

322.5

2730

8863

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

322.4

21329

138965

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

13.5

319.1

603

360

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.1

318.3

1110

1778

F32.8

ICD-10 Finland

Other depressive episodes

8.1

315.4

778

781

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.6

312.7

1579

3608

N01

ICPC

Headache

2.4

312.0

3135

11142

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

311.3

5671

25909

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

14.5

310.6

570

317

S06.0

ICD-10 Finland

Concussion

2.2

310.6

3562

13492

F60.5

ICD-10 Finland

Anankastic personality disorder

11.1

309.8

641

467

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

9.5

308.7

692

589

F90.0

ICD-10 Finland

Disturbance of activity and attention

5.7

307.9

979

1406

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

307.6

2973

10355

30680

ICD-8 Finland

Special symptoms not elsewhere classified, Cephalalgia

+∞

305.1

320

P01AB01

ATC

metronidazole; oral, rectal

1.6

304.6

12916

75378

R11

ICD-10 Finland

Nausea and vomiting

2.5

304.3

2635

8652

F10.24

ICD-10 Finland

Alcohol depence active use

6.6

303.3

853

1043

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

300.7

8145

42188

M79.7

ICD-10 Finland

Fibromyalgia

3.8

300.4

1419

3064

N05AC02

ATC

thioridazine; oral

5.2

300.3

1032

1625

R74

ICPC

Upper respiratory infection acute

1.7

299.9

8749

46275

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

299.5

9237

49615

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

52.9

299.4

389

KMAK

NOMESCO Finland

1.5

297.0

17175

107537

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

296.5

19274

123871

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

295.6

3761

14904

L28

ICPC

Limited function/disability (L)

2.0

294.3

4687

20341

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

290.5

6760

33401

R21

ICPC

Throat symptom/complaint

1.8

287.9

5767

27140

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

287.2

4889

21733

R52.9

ICD-10 Finland

Pain, unspecified

2.3

286.8

2944

10552

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

286.0

5643

26415

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

285.5

2205

6772

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.4

285.0

2730

9447

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

284.0

4467

19274

L17

ICPC

Foot/toe symptom/complaint

1.7

279.7

7828

40784

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

279.1

5132

23427

N05AL01

ATC

sulpiride; systemic

6.1

278.9

831

1098

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.2

278.3

740

834

SPAT1243

SPAT

Psychiatric/psychological examination

4.6

278.0

1069

1900

D11

ICPC

Diarrhoea

2.1

277.4

3523

13924

3092D

ICD-9 Finland

Adjustment reaction, With predominant disturbance of other emotions[AHDISTUNEISUUTENA ILMENEVÄ SOPEUTUMISHÄIRIÖ]

+∞

277.4

291

C07AB07

ATC

bisoprolol; oral

1.5

277.3

14094

85228

F33

ICD-10 Finland

Recurrent depressive disorder

6.1

276.5

824

1089

G47.3

ICD-10 Finland

Sleep apnoea

1.7

274.5

7330

37647

M03BX02

ATC

tizanidine; oral

1.5

273.2

21211

140466

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

8.1

272.4

670

669

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

271.8

5687

27094

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.2

270.7

3094

11658

30099

ICD-8 Finland

Neuroses, Unspecified neurosis

+∞

270.7

284

J01DB01

ATC

cefalexin; oral

1.6

270.4

27502

193286

-1

NOMESCO Finland

1.6

269.8

10747

61286

AA400

NOMESCO Finland

Electroconvulsive therapy

11.6

267.8

541

375

M25.5

ICD-10 Finland

Pain in joint

1.6

267.6

9315

51345

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.7

266.7

1009

1763

F43.0

ICD-10 Finland

Acute stress reaction

3.2

266.1

1589

4120

J01DA01

ATC

[U] cefalexin; systemic

1.5

264.8

20807

137655

P72

ICPC

Schizophrenia

5.0

264.5

936

1522

L01

ICPC

Neck symptom/complaint

1.9

263.7

4315

18854

J02AC01

ATC

fluconazole; systemic

1.5

261.5

12560

74679

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

261.5

12430

73736

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

261.4

8268

44402

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

8.8

260.2

608

557

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

79.4

258.5

317

F22.0

ICD-10 Finland

Delusional disorder

6.0

258.3

787

1070

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.8

257.3

1830

5333

N02AA05

ATC

oxycodone; systemic

1.9

256.4

4316

19038

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

255.0

6780

34668

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

252.0

5514

26576

F60.8

ICD-10 Finland

Other specific personality disorders

15.9

251.7

445

225

N06BA04

ATC

methylphenidate; oral

5.4

250.2

831

1256

R07.3

ICD-10 Finland

Other chest pain

2.1

250.0

3130

12262

SPAT1263

SPAT

Sampling

1.5

249.8

12894

77669

N05AB01

ATC

dixyrazine; systemic

6.8

248.6

686

816

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

248.3

8765

48303

3092E

ICD-9 Finland

Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]

+∞

247.8

260

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

13.5

247.5

467

278

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

245.4

15035

93808

D01

ICPC

Abdominal pain/cramps general

2.1

242.7

3210

12866

R02

ICPC

Shortness of breath/dyspnoea

2.0

242.5

3619

15233

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

240.7

1941

6095

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.9

237.7

651

766

N05AA01

ATC

chlorpromazine; systemic, rectal

5.7

237.4

750

1067

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

6.3

235.3

687

883

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

235.2

6422

32985

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

11.6

234.8

474

328

Z00.0

ICD-10 Finland

General medical examination

1.7

234.8

5608

27701

K07.60

ICD-10 Finland

Snapping jaw

2.8

233.8

1668

4863

F31

ICD-10 Finland

Bipolar affective disorder

7.2

233.4

618

692

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

233.2

11699

69732

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.4

232.0

764

1143

30041

ICD-8 Finland

Neuroses, Depressiva

6.7

230.4

641

771

SPAT1301

SPAT

No procedures

1.5

229.2

9321

52950

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

229.2

6025

30584

P25

ICPC

Phase of life problem adult

3.2

229.2

1312

3293

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

657.9

229.1

247

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

228.4

2433

8838

XA800

NOMESCO Finland

Neuropsychological investigation

2.8

228.4

1597

4596

H02AB06

ATC

prednisolone; systemic

1.5

228.3

14605

91449

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

23.9

228.0

352

118

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

227.8

9016

50878

30530

ICD-8 Finland

Physical disorders of presumably psychogenic origin, Cardiovascular

+∞

227.7

239

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

227.2

6441

33383

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

13.8

227.1

424

246

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.7

227.1

630

755

30050

ICD-8 Finland

Neuroses, Neurasthenia

+∞

226.8

238

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

226.3

6959

36865

F41

ICD-10 Finland

Other anxiety disorders

6.9

225.1

614

718

K59.0

ICD-10 Finland

Constipation

2.7

224.6

1767

5463

SPAT1234

SPAT

Support of social functional capacity

2.8

223.5

1586

4608

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

8.8

223.3

521

476

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

222.7

2607

9890

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

222.2

4828

23123

SPAT1283

SPAT

Restricted health certificate

1.7

220.2

5042

24539

F60.7

ICD-10 Finland

Dependent personality disorder

21.9

219.1

347

127

R06AE07

ATC

cetirizine; oral

1.4

219.0

13900

86655

UJF32

NOMESCO Finland

Coloscopy

1.6

218.8

7848

43173

F61

ICD-10 Finland

Mixed and other personality disorders

16.3

218.7

383

189

R05

ICPC

Cough

1.6

217.6

6639

35044

P16

ICPC

Acute alcohol abuse

4.9

217.0

774

1268

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

215.6

3848

17254

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

214.2

11969

72622

F33.8

ICD-10 Finland

Other recurrent depressive disorders

11.8

214.2

429

292

L02

ICPC

Back symptom/complaint

2.1

214.2

2825

11281

J01FF01

ATC

clindamycin; systemic

1.5

213.9

8573

48383

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

211.9

2308

8461

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

211.8

4111

18959

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.3

210.7

2124

7503

N05AD03

ATC

melperone; systemic

6.5

210.6

601

749

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

209.8

3193

13495

3009X

ICD-9 Finland

Neurotic disorders, Unspecified neurotic disorder

+∞

208.7

219

V03AA01

ATC

4.6

207.0

790

1391

B18.2

ICD-10 Finland

Chronic viral hepatitis C

6.3

205.7

600

770

A28

ICPC

Limited function/disability NOS

1.8

205.7

3849

17520

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

204.9

9187

53076

Z01.2

ICD-10 Finland

Dental examination

1.4

204.2

12866

79744

30010

ICD-8 Finland

Neuroses, Hysterical neurosis

+∞

203.9

214

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

134.2

202.2

235

K30

ICD-10 Finland

Functional dyspepsia

1.9

201.7

3310

14380

N03AX11

ATC

topiramate; oral

3.7

201.2

957

2071

P02

ICPC

Acute stress reaction

2.9

201.0

1337

3721

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

200.4

2771

11267

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.0

199.7

1292

3528

G43.9

ICD-10 Finland

Migraine, unspecified

2.6

198.3

1649

5257

N06AX18

ATC

reboxetine; oral

5.9

197.5

606

831

WZA90

NOMESCO Finland

Other doctors statement

1.6

197.4

7099

38916

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

19.0

197.4

327

138

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

196.9

13313

83459

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

7.6

195.4

499

529

P18

ICPC

Medication abuse

13.4

194.7

368

220

P27

ICPC

Fear of mental disorder

7.3

194.6

511

565

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

194.3

3231

14092

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

22.3

194.3

306

110

SPAT1216

SPAT

Assessment of functional ability

1.8

194.3

4208

20063

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

194.2

3505

15737

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

5.7

193.6

611

868

N06AX17

ATC

milnacipran; oral

5.8

193.4

596

822

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

18.7

193.3

322

138

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

193.2

3729

17128

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.5

193.2

1003

2333

SPAT1310

SPAT

Counselling related to known health issue

1.5

192.9

9298

54415

H03AA01

ATC

levothyroxine sodium; systemic

1.6

192.9

7086

39013

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

191.6

3971

18664

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

191.0

11750

72208

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

60.6

190.5

242

R00.2

ICD-10 Finland

Palpitations

2.2

190.0

2260

8613

F43.23

ICD-10 Finland

Adaptive disorder with other mental disorder

24.4

189.2

290

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.7

187.8

586

821

S18

ICPC

Laceration/cut

1.4

186.6

12573

78517

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

186.4

4326

21044

3000C

ICD-9 Finland

Neurotic disorders, Anxiety states[YLEISTYNYT TUSKAISUUS]

+∞

185.8

195

IBA03

NOMESCO Finland

Psychotherapy evaluation

15.3

185.7

333

175

IEY01

NOMESCO Finland

Psychoeducation, individual

12.6

184.7

358

227

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

183.6

14156

90531

E0000UV

ATC

1.4

183.5

11849

73341

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

182.7

3796

17837

3000B

ICD-9 Finland

Neurotic disorders, Anxiety states[PANIIKKIHÄIRIÖ]

+∞

181.9

191

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

9.1

181.1

414

365

IGV01

NOMESCO Finland

Psychiatric network contact

10.4

180.9

385

297

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

13.7

180.8

339

199

T74.1

ICD-10 Finland

Physical abuse

4.3

180.8

743

1408

F43.02

ICD-10 Finland

Acute stress reaction severe

21.8

180.5

286

105

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

7.9

180.0

448

456

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.2

179.6

1023

2552

R4110

NOMESCO Finland

Physiotherapy

1.5

178.9

8128

46823

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

178.4

8287

47961

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

14.3

178.3

328

184

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

177.8

3196

14302

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

24.6

177.2

271

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

13.5

176.7

333

198

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

16.8

176.7

305

145

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

176.3

8394

48815

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

8.0

175.5

432

R13

ICD-10 Finland

Dysphagia

2.2

175.4

1965

7281

M54.2

ICD-10 Finland

Cervicalgia

2.1

174.8

2277

9011

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

173.7

1781

6325

M01AE02

ATC

naproxen; oral, rectal

1.4

173.0

17968

120495

R50.9

ICD-10 Finland

Fever, unspecified

1.7

172.8

4028

19584

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

16.2

172.6

302

149

A03FA02

ATC

cisapride; oral, rectal

2.0

172.4

2412

9829

F40.8

ICD-10 Finland

Other phobic anxiety disorders

39.1

171.6

235

A03CA02

ATC

clidinium and psycholeptics; oral

2.2

171.3

1925

7139

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

5.6

171.3

546

785

N17

ICPC

Vertigo/dizziness

1.9

170.9

3039

13541

L12

ICPC

Hand/finger symptom/complaint

1.7

170.0

4197

20742

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

10.0

169.7

369

297

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

13.7

169.6

317

185

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

10.4

169.5

360

277

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

3.0

168.0

1048

2790

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

167.8

3009

13439

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

167.7

2394

9828

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.4

167.7

1578

5368

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.5

167.5

1496

4950

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

9.0

167.4

384

341

SPAT1260

SPAT

Consultation of another employee

1.6

166.4

5063

26480

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

166.0

1735

6219

F60.0

ICD-10 Finland

Paranoid personality disorder

19.3

165.9

273

113

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.4

164.1

471

592

J01FA06

ATC

roxithromycin; oral

1.4

163.7

12602

80042

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

163.3

2030

7869

S29

ICPC

Skin symptom/complaint other

1.6

163.3

4734

24435

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

163.1

2876

12764

N03AF02

ATC

oxcarbazepine; oral

2.9

163.1

1100

3085

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

162.7

3663

17601

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

162.6

1826

6766

N30.0

ICD-10 Finland

Acute cystitis

1.7

161.9

3657

17585

F43.25

ICD-10 Finland

Adaptive disorder with mixed mental disorder and behavioral disorder

60.7

161.5

205

J01CA04

ATC

amoxicillin; systemic

1.4

161.3

26388

189808

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.2

161.2

547

847

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.3

161.1

465

589

R01AD09

ATC

mometasone; nasal

1.4

161.0

14005

90749

R4140

NOMESCO Finland

Psychotherapy

12.2

160.8

316

207

30020

ICD-8 Finland

Neuroses, Phobic neurosis

+∞

160.0

168

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

12.6

159.9

310

197

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.0

159.7

699

1405

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

159.3

4701

24363

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

158.6

22098

154403

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

158.5

6032

33268

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.5

158.1

1329

4253

N05AF05

ATC

zuclopenthixol; systemic

5.3

158.0

523

787

F32.0

ICD-10 Finland

Mild depressive episode

3.4

157.9

840

1990

F21

ICD-10 Finland

Schizotypal disorder

8.5

157.7

374

352

N05CD02

ATC

nitrazepam; oral

4.2

156.4

648

1237

SPAT1312

SPAT

General health counselling

1.4

156.4

8988

54022

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

8.7

156.0

366

338

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.6

155.4

437

534

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

153.4

3113

14467

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.9

153.3

2355

9935

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

153.0

4681

24462

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

152.3

1832

6995

N06AA10

ATC

nortriptyline; systemic

3.3

152.1

830

2005

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

151.8

7706

45153

A05

ICPC

Feeling ill

2.2

151.5

1628

5905

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

151.2

4665

24424

J01EA01

ATC

trimethoprim; systemic

1.5

150.7

6870

39369

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

150.5

1528

5394

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

150.5

1731

6480

Z08

ICPC

Social welfare problem

4.9

150.3

534

871

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3032080) INR in Blood by Coagulation assay

19668

108713

1.44

318.13

7.7

1.1

1.2

inr

17.07

6202

32413

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4924

19497

1.87

316.32

3.0

3.4

4.5

pmol/l

2.82

4272

17589

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

656

799

5.88

314.13

2.3

2.5

148.9

152.2

nmol/l

0.23

568

692

(3004789) Transferrin [Mass/volume] in Serum or Plasma

8461

39255

1.62

310.13

2.6

2.4

g/l

16.54

7746

36444

(3022948) Iron [Moles/volume] in Serum or Plasma

9172

42876

1.62

307.65

2.6

2.4

13.6

14.1

umol/l

0.53

8477

39915

(3007164) IgA [Mass/volume] in Serum or Plasma

13514

61981

1.72

307.65

1.5

1.4

2.2

2.3

g/l

8.87

7807

39178

(3015377) Calcium [Moles/volume] in Serum or Plasma

20057

92254

1.86

307.65

3.0

3.4

2.4

mmol/l

3.83

17651

81415

(3017143) Hepatitis C virus Ab [Presence] in Serum

9441

40154

1.81

307.65

1.8

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

9427

39768

1.82

307.65

2.4

2.5

119.0

132.5

ug/g

2.87

7220

31644

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

47844

287289

2.48

307.65

6.0

4.5

1.8

2.1

mu/l

6.37

45058

266398

(46235355) HIV 1 and 2 tests - Meaningful Use set

15386

69551

1.79

307.65

2.2

1.9

—

(3027008) Opiates [Presence] in Urine

6134

14032

3.36

307.65

3.0

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

38032

216426

1.81

307.65

4.1

2.8

46.3

44.5

u/l

3.67

35959

204257

(3009466) Valproate [Moles/volume] in Serum or Plasma

2205

3270

4.94

307.65

5.7

5.0

371.4

373.4

umol/l

0.22

1948

2850

(3035350) Ketones [Presence] in Urine by Test strip

26118

150164

1.45

307.65

4.1

3.3

0.0

estimate

1.13

5169

27820

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

13620

65613

1.63

307.65

2.0

1.7

1.0

1.1

mg/l

1.82

9931

49574

(3002582) Erythrocytes [#/volume] in Urine

16936

84170

1.62

307.65

3.6

3.0

51.7

83.2

e6/l

3.52

13088

63537

(3027944) Amphetamines [Presence] in Urine

5948

13907

3.28

307.65

2.9

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

50969

338042

2.07

307.65

12.4

9.3

27.7

26.8

u/l

11.41

49635

327226

(3011288) Drugs identified in Urine by Screen method

5324

8018

5.11

307.65

4.1

2.4

—

(3016879) Cocaine [Presence] in Urine

5930

12713

3.59

307.65

3.0

1.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1272

1529

6.01

307.65

18.7

18.9

1444.4

3498.5

nmol/l

0.96

1222

1457

(3028300) Cannabinoids [Presence] in Urine

6158

14061

3.37

307.65

3.1

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

12190

57645

1.64

307.65

2.9

2.5

6.7

5.9

e6/l

6.00

10707

50166

(3013826) Glucose [Moles/volume] in Serum or Plasma

31234

169146

1.72

307.65

5.6

4.4

6.5

6.6

mmol/l

14.30

29221

156142

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7481

32729

1.72

307.65

2.9

2.7

6.6

8.2

umol/l

10.62

6202

28445

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

3219

9392

2.52

307.65

2.0

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

7256

26419

2.09

307.65

2.3

1.9

—

(3015736) pH of Urine

21959

114935

1.59

307.65

3.8

3.1

5.8

0.09

(3031040) Bacteria [#/volume] in Urine by Automated count

35370

196777

1.78

307.65

5.3

4.0

1313.4

1417.0

e6/l

0.12

461

2534

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

41022

227531

2.13

307.65

8.4

7.1

76.3

76.8

u/l

1.41

38861

214569

(3024561) Albumin [Mass/volume] in Serum or Plasma

23973

119864

1.75

307.65

5.0

4.8

36.4

36.0

g/l

23.21

22226

111571

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

19444

90182

1.82

307.65

3.1

2.5

55.1

58.2

u/l

9.92

17950

83358

(4198724)

1216

1007

8.73

307.65

2.5

2.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

15556

71870

1.75

307.65

1.4

1.3

1.4

1.8

u/ml

3.16

3983

20131

(3028707) Methadone [Presence] in Urine by Screen method

4440

3866

8.77

307.65

3.2

2.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21954

98526

1.97

307.65

3.7

3.1

31.4

33.1

u/l

3.52

20806

93652

(3021589) Normoblasts [#/volume] in Blood

24902

135025

1.57

307.65

10.6

8.9

0.0

e9/l

0.32

20350

111315

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

11438

41665

2.20

307.65

2.4

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

774

913

6.08

307.65

2.7

1.5

164.0

117.5

umol/l

2.15

380

471

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1211

1449

6.03

307.65

13.8

13.2

1260.1

1516.3

nmol/l

0.12

1177

1397

(3018418) pH of Serum or Plasma

17381

79865

1.80

307.65

4.2

4.1

7.4

4.55

3197

15324

(3013115) Eosinophils [#/volume] in Blood

30164

156189

1.83

307.65

7.6

6.0

0.2

e9/l

4.95

26649

138515

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

49483

317182

2.16

307.65

17.2

11.9

20.1

22.5

mg/l

50.70

40185

245785

(3001604) Monocytes [#/volume] in Blood

29272

150289

1.82

307.65

7.0

5.8

0.6

e9/l

3.32

25488

131335

(3044889) 12 lead EKG panel

34225

206220

1.47

307.65

3.7

3.3

—

(3019198) Lymphocytes [#/volume] in Blood

29964

155778

1.81

307.65

7.0

5.8

2.0

1.9

e9/l

3.19

26582

138579

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

29254

148386

1.86

307.65

6.4

5.9

9.9

11.2

umol/l

60.55

27534

140456

(3013650) Neutrophils [#/volume] in Blood by Automated count

32865

174121

1.85

307.65

11.1

8.7

4.1

4.0

e9/l

3.96

28833

152897

(3033658) Prothrombin time (PT) actual/Normal

14837

73204

1.60

307.65

4.5

3.8

94.8

92.3

29.21

14378

71342

(3006315) Basophils [#/volume] in Blood

29394

150925

1.83

307.65

7.0

5.8

0.0

e9/l

0.46

25560

131851

(3000764) Benzodiazepines [Presence] in Urine

6140

13889

3.40

307.65

3.0

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

12335

46315

2.15

307.65

2.5

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5851

21015

2.09

307.65

2.1

1.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

28151

147352

1.73

307.65

7.1

6.0

29.1

28.7

7.17

26335

138115

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

24606

121981

1.78

307.65

2.6

2.2

3700.4

76.4

nmol/l

0.50

22608

111310

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2442

5170

3.46

307.65

1.4

—

(3019150) Specific gravity of Urine by Refractometry

13238

63876

1.62

307.65

4.2

3.7

1.0

kg/l

0.41

1686

9871

(3021387) Prolactin [Units/volume] in Serum or Plasma

3887

12632

2.27

307.65

1.7

1.6

363.0

293.9

mu/l

8.10

3449

11458

(40758558) Short blood count panel - Blood

15330

74374

1.64

307.65

7.9

6.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

10142

47806

1.62

307.65

2.7

3.0

2.4

mmol/l

27.36

8704

41915

(3006504) Eosinophils/100 leukocytes in Blood

27372

141468

1.75

307.65

7.1

6.0

2.8

2.9

14.26

25597

132464

(3022096) Basophils/100 leukocytes in Blood

26621

136951

1.74

307.65

7.1

6.0

0.7

3.79

24881

128284

(3023103) Potassium [Moles/volume] in Serum or Plasma

50038

316476

2.48

307.65

18.3

13.4

3.9

4.0

mmol/l

90.82

48966

307560

(1001926) Buprenorphine [Presence] in Urine by Screen method

5421

10063

4.13

307.65

3.1

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

13718

58634

1.88

307.65

1.6

1.5

20.1

20.5

nmol/l

2.62

12192

50494

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9255

41668

1.69

307.65

2.0

1.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

27034

136932

1.79

307.65

3.3

2.8

100.3

113.6

ug/l

8.99

25203

128362

(3018095) Leukocytes [#/volume] in Urine

20002

100892

1.64

307.65

4.2

3.4

74.4

87.1

e6/l

1.42

14033

69239

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

43463

241284

2.37

307.65

4.9

3.9

14.4

14.7

pmol/l

111.01

40358

221281

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6708

26103

1.94

307.65

2.9

2.4

40.5

45.1

u/l

0.26

5752

22400

(36304419) Bacteria [Presence] in Urine

15578

75644

1.64

307.65

3.4

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

15748

76798

1.64

307.65

3.5

2.9

0.3

0.4

e6/l

2.95

11936

56776

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

12939

38095

2.85

307.65

2.2

1.6

1.5

1.4

87.70

11515

34036

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

11909

57834

1.59

307.65

1.8

1.7

—

(3023368) Bacteria identified in Blood by Culture

14212

70505

1.58

307.65

4.8

4.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

23303

109310

1.89

307.65

2.1

1.8

97.7

97.2

pmol/l

0.73

12606

56866

(3019069) Monocytes/100 leukocytes in Blood

27528

142243

1.75

307.65

7.4

6.2

8.3

8.5

25.42

25854

133976

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7616

25969

2.25

307.65

2.1

2.2

372.2

374.6

nmol/l

0.45

6933

24073

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

45839

293088

1.68

307.65

14.4

11.1

90.4

85.3

ml/min/173m2

307.65

37908

239747

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

19321

102847

1.51

307.65

4.0

3.1

46.7

58.2

ng/l

0.44

11479

62826

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

27959

135723

1.94

307.65

7.0

6.5

1.2

mmol/l

0.73

24018

114355

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

46386

297045

1.72

307.65

4.7

4.0

5.9

5.8

mmol/l

14.18

43077

274700

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1442

1025

10.21

307.65

1.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

50760

335815

2.05

307.65

18.3

13.6

72.6

74.6

umol/l

38.87

50750

335641

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1289

1214

7.68

307.65

11.9

12.3

0.6

mmol/l

1.10

1189

1116

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

19693

99972

1.62

307.65

3.7

3.1

—

0.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

36257

209545

1.68

307.65

5.0

4.0

—

(3026782) Osmolality of Urine

11485

53301

1.67

307.65

3.0

2.6

524.1

547.7

mosm/kgh2o

18.94

9838

45285

(3026008) Bacteria identified in Urine by Culture

16328

82966

1.56

307.65

3.3

2.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

26060

150755

1.43

307.65

5.4

4.5

0.0

estimate

0.11

5336

28593

(3013707) Erythrocyte sedimentation rate by Westergren method

39221

225279

1.84

307.65

4.5

3.8

10.6

11.1

mm/h

8.27

36607

209919

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9961

43578

1.76

307.65

3.9

3.5

0.8

mmol/l

0.11

9273

40787

(3023511) Choriogonadotropin [Units/volume] in Urine

2693

6975

2.83

307.65

1.5

1.3

—

(3042517) Benzodiazepines panel - Urine

394

174

16.15

307.65

3.0

2.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

49971

315397

2.49

307.65

18.2

13.3

139.5

139.7

mmol/l

66.07

48988

307151

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

17419

81597

1.75

307.65

2.5

2.0

211.6

205.3

u/l

0.22

16464

76681

(3009261) Glucose [Presence] in Urine by Test strip

26276

152229

1.43

307.65

4.1

3.4

0.0

estimate

0.05

5224

27802

(3037522) Nuclear Ab [Titer] in Serum

9252

42630

1.65

307.65

1.4

477.5

559.7

titre

3.89

1695

8542

(42870588) Differential panel, method unspecified - Blood

20634

100222

1.74

307.65

6.6

6.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

25599

122472

1.91

307.65

6.4

5.8

1.2

mmol/l

0.59

23511

111177

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

15147

67819

1.81

307.65

2.4

2.2

2.8

2.9

mg/l

3.55

13011

58310

(3009508) Creatinine [Moles/volume] in Urine

16668

86551

1.53

307.65

3.5

3.2

7.8

8.0

mmol/l

0.37

14162

73723

(3018010) Neutrophils/100 leukocytes in Blood

27837

145167

1.73

307.65

6.9

5.8

56.5

56.7

2.16

26106

136628

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

13878

67804

1.60

307.65

1.8

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

11217

44588

1.99

307.65

1.8

1.7

1143.8

1176.5

nmol/l

3.19

8797

33908

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

11659

56679

1.58

307.65

1.7

1.6

32254915.2

38438230.0

pmol/l

0.51

9887

47625

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7850

34446

1.72

307.65

6.4

6.0

1.0

mmol/l

0.58

7344

32265

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4369

14998

2.16

307.65

2.5

2.3

5896.6

6174.2

u/l

0.19

1432

6279

(3007853) Bacteria identified in Skin by Aerobe culture

7518

34010

1.66

303.81

1.9

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9727

46878

1.57

303.49

2.9

2.6

1.2

1.1

e6/l

0.10

5289

26200

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6489

28255

1.71

302.37

1.9

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

9177

43673

1.59

302.00

3.1

2.7

4.1

3.1

e6/l

7.08

4746

23153

(3002385) Erythrocyte distribution width [Ratio]

42173

269006

1.49

300.26

20.6

14.4

13.6

0.31

41519

263364

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6441

28090

1.71

298.11

1.9

1.7

—

(40768797) Stomach Pathology biopsy report

8396

39274

1.61

296.24

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10848

53894

1.53

294.42

1.3

31.1

33.9

iu/ml

0.32

2865

17301

(36660697) Celiac disease serology panel - Serum

5924

25417

1.73

290.18

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

13183

68466

1.48

288.30

3.9

3.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1082

2173

3.58

287.51

1.8

1.3

1.5

1.4

promille

0.66

810

1699

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

10413

51693

1.53

281.90

4.0

3.4

277.0

508.4

ng/l

5.75

6713

37213

(40761511) CBC panel - Blood by Automated count

50126

334203

1.79

277.63

15.7

11.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

5339

22519

1.75

276.84

7.1

7.4

1.4

1.3

mmol/l

0.85

5103

21769

(3019832) Treponema pallidum Ab [Presence] in Serum

8402

40120

1.57

269.07

1.8

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5490

23591

1.72

265.97

4.7

3.9

5.9

5.8

kpa

8.59

5293

22933

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7728

36352

1.59

263.28

2.7

2.5

22.6

23.3

3.48

6669

31172

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

36750

230461

1.40

263.10

3.8

3.2

—

(3002032) Base excess in Venous blood by calculation

5460

23522

1.72

261.85

4.7

4.0

1.9

1.8

mmol/l

0.91

4464

19329

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1644

4506

2.63

259.19

1.6

1.5

—

(3012544) pH of Venous blood

5610

24425

1.70

258.71

4.7

3.9

7.4

0.98

122

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4657

19287

1.78

255.94

1.8

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10098

50914

1.50

249.88

1.3

7.7

11.6

u/ml

6.10

3676

20633

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

43058

278758

1.45

247.09

5.8

5.1

38.8

39.0

mmol/mol

4.84

40258

260688

(3042936) Bacteria identified in Isolate by Culture

8137

39426

1.54

241.59

2.2

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

4580

19237

1.75

239.06

4.1

3.3

4.8

4.7

kpa

4.33

4394

18639

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1461

3945

2.67

236.93

1.7

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5768

25873

1.65

236.21

1.6

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

4223

17425

1.78

234.02

1.4

1.3

23.6

27.3

iu/l

10.61

3503

15125

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3945

16038

1.80

229.53

3.8

3.4

5.2

5.1

kpa

5.70

3676

14848

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5214

22950

1.67

229.16

1.2

125.3

146.0

iu/ml

3.08

1738

8978

(3009343) pH of Capillary blood

3893

15835

1.80

225.97

3.8

3.4

7.4

1.21

514

2083

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8353

41278

1.51

224.71

2.3

2.1

29.5

29.7

1.23

8088

40079

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5665

25605

1.63

224.38

2.6

2.3

0.2

g/l

9.40

5208

23968

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3782

15286

1.81

224.09

3.7

3.3

1.6

mmol/l

0.11

2804

11158

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3243

12516

1.89

222.23

5.0

4.4

24.2

mmol/l

0.03

2895

11347

(3000991) Gas panel - Venous blood

4984

21882

1.68

220.69

8.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

6832

32438

1.56

220.06

7.6

7.3

104.3

104.5

mmol/l

3.56

6666

31803

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2135

7115

2.17

218.67

1.3

525.0

522.2

mg/l

0.03

2023

6796

(3023183) Ammonium ion [Moles/volume] in Plasma

1687

5140

2.37

213.02

2.8

2.9

33.1

34.6

umol/l

1.72

1457

4385

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3551

14296

1.81

212.72

1.7

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3723

15281

1.78

209.06

1.6

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

16486

93256

1.36

207.98

2.6

2.2

—

(3000494) Fungus identified in Specimen by Culture

7037

34046

1.53

207.29

1.6

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2759

10330

1.94

206.52

1.4

9.6

u/l

0.08

2182

8548

(40760892) CBC W Ordered Manual Differential panel - Blood

13014

70986

1.39

204.67

5.1

4.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1908

6253

2.20

203.39

1.3

3.7

mmol/l

0.04

1773

5885

(3005719) IgG [Mass/volume] in Serum or Plasma

4992

22405

1.64

202.02

2.7

10.3

10.6

g/l

6.67

4528

20573

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1910

6291

2.19

201.10

1.5

3308.1

1747.8

e6/l

0.36

1523

5109

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1908

6287

2.19

200.69

1.4

33.8

29.2

e6/l

0.17

1435

4862

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4066

17325

1.72

200.08

1.1

1.0

—

(3003396) Base excess in Arterial blood by calculation

6097

28842

1.56

197.92

7.8

7.5

1.1

1.0

mmol/l

1.77

4832

22667

(3027801) Oxygen [Partial pressure] in Arterial blood

6088

28830

1.56

196.61

7.7

7.5

12.3

12.8

kpa

10.70

5821

27514

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6089

28846

1.56

196.28

7.8

7.6

5.1

kpa

5.31

5828

27536

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4689

20862

1.65

196.06

2.4

2.3

22.8

23.2

au/ml

0.08

225

1406

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4334

19097

1.66

187.72

1.3

44.9

48.1

au/ml

0.28

108

826

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2165

7725

2.03

185.21

1.4

293.4

276.3

ug/g

2.19

1162

4467

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

769

1686

3.26

178.92

1.8

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1608

5176

2.24

178.71

1.4

1.3

23.8

25.8

u/l

1.52

1295

4317

(3013512) EKG study

13840

77599

1.35

178.69

3.9

3.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3098

12635

1.78

176.74

1.1

9.5

10.8

u/ml

0.06

194

(3044290) Cell count panel - Cerebral spinal fluid

1766

5943

2.14

176.01

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

14198

80217

1.34

173.20

4.6

3.7

0.0

estimate

4.43

5201

27643

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2343

8808

1.92

172.65

2.3

2.4

386.6

532.2

ug/l

1.73

2148

8202

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2713

10751

1.83

169.93

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2297

8637

1.92

169.08

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2300

8665

1.92

168.33

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2732

10894

1.82

167.66

1.8

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2272

8558

1.92

166.33

1.2

—

(3016502) Oxygen saturation in Arterial blood

5378

25730

1.53

163.82

8.2

8.0

95.6

95.9

3.60

5201

24717

(3020779) Urea [Moles/volume] in Serum or Plasma

4851

22681

1.57

163.73

8.8

7.8

8.1

9.2

mmol/l

27.23

4624

21685

(3025941) Bacteria identified in Stool by Culture

4067

18259

1.62

162.62

1.3

1.2

—

(3007461) Platelets [#/volume] in Blood

52439

359833

1.88

162.35

25.9

17.4

261.5

255.2

e9/l

92.12

51459

350972

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

12577

70550

1.34

158.14

2.5

2.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

4455

20640

1.58

156.03

1.4

1.3

256.5

242.5

u/ml

0.19

4097

19143

(3035941) MCH [Entitic mass]

52445

360184

1.86

155.83

25.8

17.3

30.2

5.41

51938

355669

(3019225) pH of Specimen

5364

25912

1.52

155.75

4.3

4.0

—

(3024731) MCV [Entitic volume]

52449

360226

1.86

155.70

25.8

17.4

90.4

90.5

2.85

51940

355698

(3026361) Erythrocytes [#/volume] in Blood

52451

360270

1.86

155.13

25.9

17.4

4.5

e12/l

20.35

51371

350536

(3010813) Leukocytes [#/volume] in Blood

52458

360355

1.86

154.66

26.0

17.4

6.9

6.6

e9/l

72.95

51378

350590

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2909

12105

1.74

154.32

1.3

1.2

0.6

0.9

u/ml

0.86

233

1039

(3000963) Hemoglobin [Mass/volume] in Blood

52455

360418

1.85

152.69

26.1

17.5

135.5

136.4

g/l

41.89

51948

355952

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3683

16404

1.63

151.58

7.3

7.4

24.9

24.8

mmol/l

1.63

3648

16266

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

23474

143807

1.28

151.35

4.2

3.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3834

17358

1.61

147.56

1.9

1.8

1.3

g/l

0.03

3500

15925

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

605

1298

3.33

145.61

1.9

1.5

1938474.9

1807306.9

iu/ml

0.09

(3048929) Epstein Barr virus Ab [Presence] in Serum

2718

11318

1.74

143.58

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

4323

20315

1.55

141.63

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

19551

117913

1.27

139.27

4.3

3.4

—

(3022313) Gas panel - Capillary blood

2714

11438

1.72

137.22

4.0

3.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4932

24036

1.50

136.21

8.6

8.4

123.3

122.0

g/l

4.34

4772

23131

(3052851) Hemolysis interference index of Serum or Plasma

2077

8160

1.84

133.10

3.0

3.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4549

21926

1.51

132.22

4.1

3.7

1.2

mmol/l

2.34

3978

19171

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

13398

77538

1.30

129.97

1.7

1.6

1.5

1.4

mmol/l

43.14

11606

65862

(3019060) Gas panel - Arterial blood

3539

16197

1.59

129.54

5.4

4.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2421

10103

1.73

126.57

4.1

3.6

24.8

mmol/l

0.49

2290

9384

(3017181) Myelocytes/100 leukocytes in Blood

4927

24378

1.48

125.69

4.4

4.1

0.9

0.08

1344

6457

(3027945) Reticulocytes/100 erythrocytes in Blood

5537

28035

1.44

125.32

2.8

2.6

1.8

0.06

4881

25016

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

12144

69697

1.30

124.40

3.1

2.8

1000.7

1185.9

ng/l

3.76

9923

58759

(3004716) Salmonella sp identified in Stool by Organism specific culture

3751

17613

1.55

122.55

1.3

1.4

—

(21494755) Public health laboratory ask at order entry panel

4078

41432

0.67

119.42

1.3

—

(3007463) Buprenorphine [Presence] in Urine

131

14.77

118.67

7.6

9.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2667

11646

1.65

117.71

3.8

2.9

1.6

1.3

20.70

2649

11591

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2209

9174

1.74

117.31

1.9

1.7

0.2

g/l

0.80

2084

8717

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2258

9460

1.72

116.22

1.8

1.7

1.2

g/l

0.88

2136

9023

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1853

7347

1.81

115.07

1.2

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

4672

23264

1.46

114.79

4.5

4.2

0.1

0.12

1221

6005

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4519

22388

1.47

113.92

2.5

2.2

12.0

12.7

nmol/l

5.83

3946

20308

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1463

5394

1.95

113.52

1.4

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4088

19862

1.50

113.52

3.9

4.0

85.0

88.2

ng/l

1.23

3543

17348

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1463

5397

1.95

113.34

1.4

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6383

33752

1.39

112.03

7.4

6.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3383

15855

1.55

111.07

1.1

161.6

197.8

titre

0.33

457

(3002179) Metamyelocytes/100 leukocytes in Blood

4480

22285

1.46

110.44

4.1

4.0

0.7

0.05

967

4713

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

241

309

5.55

109.96

1.2

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2586

11426

1.63

108.80

3.8

2.9

0.7

0.52

2480

10968

(3023410) Appearance of Cerebral spinal fluid

918

2880

2.28

108.14

1.6

—

(4010399)

4202

20761

1.47

107.08

1.4

—

(1616796) Gas panel - Central venous blood

1519

5802

1.88

106.05

3.9

3.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1555

5995

1.86

105.48

3.5

3.1

8.8

8.5

kpa

6.17

1459

5569

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

10181

58171

1.30

104.94

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3242

15250

1.54

104.48

4.1

3.3

131.4

129.9

g/l

3.32

3164

14896

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2895

13289

1.57

103.92

9.4

10.1

24.4

24.3

mmol/l

0.72

2672

12499

(3003181) Sodium [Moles/volume] in Urine

1158

4066

2.04

102.95

1.5

1.4

59.6

64.7

mmol/l

3.29

901

3209

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1360

5057

1.93

102.90

1.1

—

(3025159) Blasts/100 leukocytes in Blood

4402

22117

1.45

102.60

4.6

4.2

0.1

0.2

2.67

1035

5116

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3348

15927

1.52

102.39

9.6

1.5

1.4

12.36

3334

15823

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3344

15910

1.52

102.20

9.7

0.7

0.33

3331

15818

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1606

6318

1.83

102.17

3.2

2.9

24.7

24.6

mmol/l

0.47

1437

5556

(3007566) Smooth muscle Ab [Titer] in Serum

2029

8557

1.71

101.76

1.3

81.5

123.6

titre

3.27

171

815

(40761535) Cells panel - Urine sediment

4379

22023

1.44

101.48

3.9

3.3

—

(3022145) Colonoscopy Study observation

6241

33373

1.37

101.42

1.3

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

201

238

6.00

99.08

6.9

7.9

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3347

16031

1.51

99.02

9.8

9.7

93.7

94.1

3.37

3335

15969

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2572

11614

1.60

98.85

1.6

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1367

5166

1.90

98.54

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1423

5456

1.87

98.15

1.5

1.4

0.4

nmol/l

0.61

1130

4288

(3009542) Hematocrit [Volume Fraction] of Blood

44766

302037

1.28

97.06

18.4

12.7

40.0

40.3

7.92

33514

233029

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3280

15713

1.51

96.89

8.2

6.9

24.7

24.6

mmol/l

1.30

3101

14577

(3008898) HLA-B27 [Presence]

2605

11857

1.58

96.78

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1200

4398

1.95

94.66

1.3

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1093

3879

2.02

94.38

2.0

1.8

5390.3

3375.0

titre

0.53

155

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1651

6717

1.76

93.91

1.3

1.2

—

(3010421) pH of Blood

1697

6972

1.75

93.32

4.4

3.6

7.4

7.96

1451

5889

(3008295) Osmolality of Serum or Plasma

785

2466

2.27

92.22

1.6

1.5

282.0

280.1

mosm/kgh2o

1.37

589

1970

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1714

7094

1.74

91.84

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1562

6321

1.77

90.45

1.3

267.2

258.1

u/ml

0.60

1026

4063

(3035637) Corticotropin [Mass/volume] in Plasma

1017

3579

2.03

89.86

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2580

11926

1.56

89.52

1.4

1.3

221.7

224.1

miu/ml

0.11

1060

5808

(40768804) Tissue Pathology biopsy report

19913

124456

1.21

88.84

2.1

2.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4128

21023

1.42

88.78

2.5

2.2

7.0

7.5

ug/l

0.50

3503

18479

(3022217) INR in Platelet poor plasma by Coagulation assay

5983

32410

1.35

88.50

18.3

21.2

1.2

1.3

inr

4.76

850

4851

(3034770) Mitochondria Ab [Titer] in Serum

1947

8455

1.66

87.34

1.3

1.2

862.2

969.2

titre

0.23

244

(3029634) Reagin Ab [Titer] in Serum by VDRL

1233

4691

1.88

87.05

2.4

2.1

10.1

5.9

titre

0.68

122

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

455

1124

2.88

86.97

1.4

602.0

706.3

mu/l

0.39

426

1073

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

771

2472

2.23

86.34

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

460

1149

2.85

86.21

1.4

73.0

72.8

0.15

431

1098

(3027315) Oxygen [Partial pressure] in Blood

1495

6058

1.77

86.15

4.6

3.7

8.9

8.7

kpa

3.04

1460

5923

(3012501) Base excess in Blood by calculation

1486

6016

1.77

85.90

4.6

3.7

2.5

mmol/l

0.04

997

4034

(3013290) Carbon dioxide [Partial pressure] in Blood

1486

6018

1.77

85.80

4.6

3.7

5.1

5.0

kpa

4.81

1451

5884

(3036489) Thrombin time

2473

11436

1.56

85.58

2.3

2.1

21.3

0.12

2122

9844

(3018405) Lactate [Moles/volume] in Arterial blood

1960

8586

1.64

84.96

4.8

4.1

1.4

mmol/l

0.26

1938

8431

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

839

2803

2.14

84.94

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

785

2556

2.19

84.70

2.0

2.3

20.9

19.6

nmol/l

2.56

731

2443

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2119

9500

1.60

83.65

1.9

1.8

—

(3020891) Body temperature

2198

9979

1.58

82.30

6.1

4.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2152

9739

1.59

81.67

1.9

1.7

38.9

40.3

nmol/l

1.70

2097

9552

(3024928) Oxygen saturation in Venous blood

1346

5373

1.79

81.55

3.8

3.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

13971

84835

1.22

81.52

3.7

3.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1944

8590

1.63

81.38

1.3

25.7

37.4

u/ml

1.20

536

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

785

2606

2.15

80.76

1.5

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3959

20343

1.41

80.63

2.4

2.6

66.6

66.7

g/l

0.25

3601

18607

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2647

12592

1.51

80.42

1.7

1.6

3.8

3.4

mg/l

1.49

2052

8465

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

602

1791

2.40

79.97

1.4

1.3

5.3

5.2

umol/l

0.36

555

1656

(3016018) Differential panel - Cerebral spinal fluid

899

3170

2.03

79.03

1.4

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

669

2106

2.27

78.26

3.2

3.3

29.3

26.8

mu/l

0.79

625

1983

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5531

30127

1.33

78.14

4.0

4.3

231.4

242.1

u/l

6.79

5189

28619

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1537

6455

1.71

78.08

1.3

1.2

36.9

45.3

u/ml

1.21

144

642

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

765

2552

2.14

77.76

1.2

34.9

44.9

mg/l

6.02

633

2134

(3023520) Reticulocytes [#/volume] in Blood

3967

20577

1.39

76.31

2.7

2.6

72.4

70.5

e9/l

2.38

2923

15431

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

46258

315202

1.27

76.15

4.8

4.4

2.8

mmol/l

0.98

43021

294358

(3026389) Candida sp identified in Specimen by Organism specific culture

1137

4412

1.84

75.49

1.4

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

739

2466

2.14

75.07

1.1

232.4

268.9

mg/l

3.49

637

2176

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1565

6681

1.68

74.83

2.1

1.9

190.8

198.4

pmol/l

1.81

1481

6391

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

537

1563

2.45

74.81

1.1

3.4

5.2

nmol/l

0.39

320

(3021901) Oxygen saturation in Capillary blood

1155

4532

1.82

74.01

2.9

2.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2322

10930

1.53

73.99

4.5

3.8

51.2

48.7

4.82

2296

10813

(1002224) Polysomnography panel

2867

14156

1.46

72.30

1.1

—

(4027681)

623

1971

2.25

72.07

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

1687

7415

1.63

72.05

5.2

4.3

3.8

3.9

mmol/l

3.91

1581

7003

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1534

6588

1.67

71.69

1.5

1.4

18.1

20.3

u/ml

0.29

136

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

714

2404

2.12

70.93

1.1

—

(3037121) Protein [Mass/volume] in Urine

2029

9370

1.56

70.43

3.3

0.3

g/l

1.53

909

4162

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1536

6645

1.66

69.79

1.5

—

(3017509) Phencyclidine [Presence] in Urine

206

346

4.23

69.79

2.3

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2467

11909

1.49

69.66

4.2

3.3

25.4

25.3

mmol/l

1.04

2398

11522

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

670

2221

2.15

69.24

1.2

1.3

2.0

mmol/l

0.83

616

2070

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

11.43

69.14

1.4

1.3

423.5

593.3

nmol/l

1.08

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

5065

27708

1.33

68.90

3.9

3.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

497

1453

2.44

68.63

1.7

1.5

20.5

26.4

umol/l

4.66

472

1382

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

153

203

5.35

67.62

1.1

1.3

53.7

43.9

mg/l

1.30

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1947

8995

1.55

67.43

2.8

2.6

178.7

183.5

1.46

1836

8528

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

45597

311021

1.24

67.15

4.4

4.0

4.7

mmol/l

24.87

42664

292220

(1761868) Lipid panel - Serum or Plasma

15417

123516

0.84

66.97

2.7

2.6

—

(40767503) Oxygen content in Capillary blood by calculation

1334

5628

1.70

66.62

2.9

2.4

17.0

16.6

1.92

712

2832

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1429

6149

1.66

66.27

1.5

107.9

111.1

u/ml

0.45

295

1392

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6947

60149

0.79

65.60

3.7

3.8

21.6

21.7

0.14

2625

25973

(3028271) Lactate [Moles/volume] in Capillary blood

1054

4177

1.80

65.41

2.2

1.8

1.7

mmol/l

1.26

1032

4074

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2493

12229

1.47

64.87

1.5

9.6

14.7

u/ml

1.78

353

(3013005) Retinol [Moles/volume] in Serum or Plasma

436

1233

2.52

64.57

2.0

1.8

2.0

1.9

umol/l

0.58

411

1155

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

663

2267

2.09

63.34

1.1

294.7

419.3

mg/l

0.47

590

2045

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1865

8658

1.54

63.17

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1427

6242

1.64

62.08

1.4

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2067

9854

1.51

61.90

2.6

2.3

94.8

92.9

2.91

1923

9153

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

45249

308957

1.22

61.51

4.4

4.0

1.4

1.5

mmol/l

167.20

42165

289270

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1733

7967

1.56

61.29

1.3

8.8

9.4

u/ml

0.13

246

1251

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1431

6285

1.63

61.26

1.7

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1178

4924

1.71

60.85

1.6

0.7

0.8

g/l

2.31

907

3693

(3017732) Neutrophils [#/volume] in Blood

3986

21426

1.34

60.74

3.2

2.6

4.2

4.1

e9/l

1.87

3083

17111

(3034274) Bile acid [Moles/volume] in Serum --fasting

1196

5033

1.70

60.29

2.0

2.2

5.7

6.7

umol/l

1.53

876

3679

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2537

12700

1.44

59.23

2.0

39.8

39.7

u/l

0.07

2301

11443

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2016

9650

1.50

59.18

1.7

1.6

230.5

308.5

titre

0.62

387

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1009

4070

1.77

59.05

1.3

0.2

nmol/l

0.96

244

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1390

6120

1.63

58.92

6.8

5.8

1124.2

1795.2

iu/ml

0.38

183

903

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1012

4092

1.77

58.74

1.3

1.8

1.2

nmol/l

0.27

973

3943

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1974

9442

1.50

58.14

1.5

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1383

6102

1.62

58.13

1.8

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2275

11199

1.46

58.03

2.2

1.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3895

35752

0.75

57.72

1.6

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1695

7860

1.54

57.67

1.3

8.2

6.3

u/ml

0.37

159

818

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4945

43954

0.78

57.29

2.7

0.6

0.7

ug/l

17.77

3172

26176

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

603

2070

2.08

57.07

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

600

2058

2.08

56.91

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

835

3217

1.85

56.77

1.4

1.3

23.3

31.0

nmol/l

0.73

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1971

9510

1.49

55.62

2.2

2.0

2.1

2.3

ug/l

0.33

1742

8424

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1916

9194

1.49

55.54

3.2

2.7

3.5

3.6

g/l

1.56

1816

8773

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

521

1708

2.17

55.45

1.1

1.0

1.1

u/l

0.69

229

766

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

393

1141

2.45

55.19

2.1

1.8

28.3

29.0

umol/l

0.58

381

1099

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1750

8271

1.52

54.54

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

43706

298204

1.20

54.17

3.9

3.6

1.4

1.3

mmol/l

108.47

40451

278057

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2746

14175

1.39

53.77

10.3

10.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

325

871

2.65

53.67

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

12376

76699

1.19

53.38

2.6

2.5

2157.4

3873.3

umol/l

9.27

10711

67669

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2070

10180

1.46

53.01

2.1

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

908

3676

1.76

52.52

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

356

1017

2.49

51.76

1.5

1.4

13.9

15.0

pmol/l

2.85

285

873

(3016038) Potassium [Moles/volume] in Urine

477

1554

2.19

51.60

1.4

1.3

33.1

33.7

mmol/l

0.21

414

1340

(3004588) Protein electrophoresis panel - Serum or Plasma

3106

16470

1.36

51.46

2.2

2.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1400

6386

1.57

51.21

1.3

1.2

2.5

6.3

u/ml

2.13

480

(3022806) Fractional oxyhemoglobin in Capillary blood

855

3433

1.78

50.87

2.2

1.7

90.4

90.1

0.89

840

3375

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1652

7852

1.51

50.12

1.9

15.0

18.5

iu/l

0.13

576

3010

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1072

4611

1.66

49.82

3.4

2.9

562.7

7231.1

u/ml

1.41

249

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1374

6287

1.56

49.58

1.2

20.4

14.7

u/ml

0.19

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9188

75477

0.83

49.46

4.1

4.3

2.6

ug/l

0.05

8194

68796

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

490

1643

2.12

49.36

1.4

1.5

5.6

5.9

u/l

0.26

415

1386

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

595

2153

1.97

48.84

2.8

2.6

814.5

738.8

e6/l

0.58

222

873

(40761536) Microorganisms panel - Urine sediment

4652

26280

1.28

48.80

4.6

3.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1936

9559

1.45

48.53

1.1

4.9

5.3

u/ml

0.11

205

1379

(3021367) Citalopram [Moles/volume] in Serum or Plasma

13.45

47.69

1.3

1.7

137.6

136.8

nmol/l

0.01

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

383

1177

2.31

47.58

2.7

2.4

52.3

54.1

umol/l

0.52

324

986

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

721

2806

1.83

47.55

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1627

7794

1.49

47.52

1.3

1.5

9.0

14.6

iu/ml

1.70

199

(21494815) CD4 cells/100 lymphocytes in Specimen

682

2609

1.86

47.48

2.5

2.2

43.2

41.2

0.56

342

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2667

13989

1.37

47.26

2.4

2.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1034

4468

1.65

47.23

1.8

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6382

37519

1.23

47.21

1.8

—

(3025130) Human papilloma virus identified in Specimen

1115

4912

1.62

47.18

1.7

—

(3003338) MCHC [Mass/volume]

41339

281572

1.17

47.05

22.3

14.9

332.9

g/l

0.41

41078

279492

(3006922) Hepatitis E virus Ab [Presence] in Serum

597

2197

1.94

46.71

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

823

3352

1.75

46.67

7.2

6.2

11.0

11.3

mg/l

0.94

748

3092

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

457

1532

2.12

46.10

1.1

—

(3011412) CD3 cells [#/volume] in Blood

735

2907

1.80

46.02

2.6

2.4

1.3

1.1

e9/l

4.81

444

1726

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

446

1488

2.13

45.55

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1333

6186

1.54

45.19

2.3

2.1

133.2

131.2

g/l

2.15

990

4535

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

336

1002

2.38

44.67

1.2

110.7

111.2

0.11

303

894

(3027135) IgG subclass 1 [Mass/volume] in Serum

772

3134

1.76

44.30

1.5

1.3

6.5

6.7

g/l

0.90

563

2145

(3001186) Copper [Moles/volume] in Serum or Plasma

264

703

2.67

44.25

1.4

1.3

17.0

16.8

umol/l

0.25

232

626

(3024139) IgG subclass 3 [Mass/volume] in Serum

771

3130

1.76

44.24

1.5

1.3

0.4

g/l

2.28

566

2147

(4062490)

773

3142

1.75

44.17

1.5

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

771

3132

1.75

44.15

1.5

1.3

2.9

3.0

g/l

0.39

559

2148

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5855

34334

1.23

44.13

4.2

30.7

32.2

20.70

4250

24178

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1642

8018

1.47

43.58

1.9

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1110

4984

1.59

43.46

1.3

1.2

4.0

3.8

u/ml

0.26

509

2240

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

353

1091

2.30

43.35

1.2

0.3

g/l

0.31

280

863

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2280

11850

1.38

42.70

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

844

3563

1.69

42.15

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

844

3568

1.69

41.93

1.5

1.4

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

9.25

41.92

1.6

1.5

301.4

178.9

nmol/l

1.04

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1133

5156

1.57

41.90

1.3

1.2

3.7

u/ml

0.02

379

1791

(3005988) Vibrio sp identified in Specimen by Organism specific culture

844

3571

1.69

41.80

1.5

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

543

2021

1.91

41.17

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

848

3610

1.67

41.06

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

864

3698

1.67

40.99

1.5

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3669

20570

1.28

40.59

3.0

2.7

144.3

177.6

ng/l

5.20

3265

18596

(3047181) Lactate [Moles/volume] in Blood

1697

8455

1.44

40.51

6.3

5.5

1.3

mmol/l

0.99

1497

7453

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

543

2033

1.90

40.46

1.1

—

(3036180) Methadone [Presence] in Urine

9.69

40.33

2.5

3.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1030

4633

1.59

40.05

1.6

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

246

666

2.62

40.00

1.4

1.2

134.6

131.0

nmol/l

0.10

176

503

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

785

3301

1.70

39.80

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

844

3619

1.66

39.77

1.5

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

1012

4543

1.59

39.69

4.2

3.3

64.3

65.4

0.82

1005

4526

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

355

1147

2.20

39.33

1.2

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

10.16

39.33

1.7

1.5

334.8

231.6

nmol/l

0.45

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2182

11415

1.37

39.22

1.8

1.5

g/l

0.20

1883

9798

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1448

7047

1.47

39.10

2.2

0.0

g/l

1.29

1324

6454

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

551

2102

1.87

38.80

1.2

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

239

648

2.62

38.77

1.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1054

4804

1.57

38.74

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1743

8807

1.42

38.50

2.2

2.3

3.0

3.1

g/l

4.18

1373

6854

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

507

1889

1.91

38.36

2.2

2.1

100.6

97.2

1.27

472

1754

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

482

1768

1.94

38.19

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1589

7916

1.44

37.96

2.3

2.4

0.6

0.8

g/l

1.66

1391

6835

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

608

2412

1.80

37.79

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

608

2414

1.79

37.69

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

608

2418

1.79

37.49

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

602

2387

1.80

37.49

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

635

2562

1.77

37.31

1.7

1.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

602

2391

1.79

37.28

1.2

—

(3012516) Albumin [Mass/volume] in Urine

12478

79186

1.15

37.15

3.4

3.3

503.7

416.7

mg/l

1.02

7978

49676

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

602

2394

1.79

37.13

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1465

7223

1.45

36.99

2.1

2.2

38.8

37.9

g/l

7.00

1281

6230

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

250

710

2.50

36.98

1.2

1.3

93.6

92.5

0.22

244

700

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

819

3554

1.64

36.89

1.7

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1819

9329

1.39

36.87

2.1

2.2

7.1

7.4

g/l

5.78

1405

7003

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

192

476

2.86

36.82

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1339

6498

1.47

36.70

2.1

2.3

0.0

g/l

0.12

1220

5922

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

918

4104

1.60

36.66

1.1

1.5

g/l

0.01

826

3727

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1815

9319

1.39

36.55

2.1

2.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

552

2149

1.83

36.50

2.2

2.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

881

3906

1.61

36.42

1.3

1.2

58.8

51.8

u/ml

0.26

259

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1044

4819

1.55

36.32

1.1

120.1

118.4

0.87

946

4370

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1811

9306

1.39

36.29

2.1

2.2

3.7

3.8

g/l

1.34

1350

6656

(3019420) Tryptase [Mass/volume] in Serum or Plasma

457

1678

1.94

36.13

1.3

1.5

6.1

8.2

ug/l

3.51

418

1509

(3040151) Glucose [Moles/volume] in Capillary blood

701

2937

1.70

36.07

6.9

7.9

7.2

7.3

mmol/l

0.40

571

2394

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2660

24209

0.77

36.06

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1320

6415

1.47

35.92

2.2

2.3

0.0

g/l

0.00

1219

5902

(3012920) Ethanol [Mass/volume] in Serum or Plasma

9.58

35.77

1.7

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

246

705

2.48

35.73

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1069

4984

1.53

35.55

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1702

8685

1.40

35.54

2.1

2.2

9.9

10.2

g/l

2.43

1440

7282

(3017315) Amylase [Enzymatic activity/volume] in Urine

423

1521

1.98

35.52

1.3

1.2

256.3

336.1

u/l

1.03

396

1425

(4306422)

1073

5013

1.53

35.34

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.59

35.12

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

558

2207

1.80

35.07

1.2

—

(3051651) Icteric interference index of Serum or Plasma

438

1603

1.94

34.98

4.1

3.8

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

12.41

34.94

3.0

2.5

2.6

2.1

ug/l

0.49

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

602

2440

1.76

34.86

1.2

1.1

65.6

66.1

u/ml

—

(1175426) CD3 cells/100 lymphocytes in Blood

583

2343

1.77

34.75

2.2

2.1

74.7

73.0

2.10

564

2254

(3039443) Prostate specific Ag panel - Serum or Plasma

453

5814

0.55

34.73

1.5

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

552

2185

1.80

34.62

1.4

11.1

11.9

umol/l

2.38

512

2092

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2001

10538

1.36

34.46

5.6

4.9

1.9

1.7

8.77

1880

9836

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

302

965

2.22

34.45

3.0

2.9

29.4

28.4

umol/l

0.60

223

735

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2607

14277

1.31

34.35

3.0

2.5

0.3

e6/l

0.47

2523

13844

(3020682) Albumin/Creatinine [Ratio] in Urine

13001

83126

1.14

34.17

4.1

4.0

9.8

9.0

mg/mmol

0.84

8227

52465

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1484

7446

1.42

34.10

1.1

1.6

1.8

u/ml

0.18

667

2998

(3007930) Methemoglobin/Hemoglobin.total in Blood

1963

10325

1.36

34.08

5.7

5.0

0.9

0.27

1847

9641

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

950

4372

1.55

33.53

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

391

1397

1.99

33.46

40.2

35.8

7.4

ug/l

0.05

361

1280

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

540

2147

1.79

33.39

2.7

2.6

543.1

527.4

e6/l

0.25

460

1777

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1597

8150

1.40

33.33

2.0

2.1

10.7

mg/l

0.04

1483

7650

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

571

2313

1.76

33.16

2.2

2.1

11.9

14.0

3.86

288

1127

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1061

5017

1.51

33.06

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

866

3916

1.58

33.01

2.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

780

3448

1.61

32.69

1.6

36.5

33.8

iu/ml

0.16

159

(3003888) Timothy IgE Ab [Units/volume] in Serum

1348

6703

1.44

32.55

1.1

5.8

5.9

u/ml

0.02

763

3445

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

283

905

2.22

32.26

1.2

—

(3001556) Androgen free Index in Serum or Plasma

150

349

3.05

32.16

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

523

2086

1.78

32.03

2.8

2.6

0.2

e9/l

0.64

457

1781

(44790049)

704

3049

1.64

32.02

1.7

1.6

—

(44790047)

704

3050

1.64

31.98

1.7

1.6

—

(44806118)

704

3050

1.64

31.98

1.7

1.6

—

(44790048)

704

3051

1.64

31.94

1.7

1.6

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

12.02

31.90

1.3

173.9

181.2

nmol/l

0.06

(3045414) Leukocytes [Presence] in Urine

2443

13402

1.31

31.76

1.9

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

755

3336

1.61

31.71

1.5

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

407

1504

1.92

31.66

1.3

60.1

65.2

0.40

181

(44813793)

578

2385

1.72

31.50

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

812

3658

1.58

31.47

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

739

3259

1.62

31.29

2.1

1.9

22.0

26.2

mg/l

1.21

199

859

(3011985) Renin [Units/volume] in Plasma

879

4056

1.54

30.70

1.6

71.0

62.2

mu/l

0.52

778

3646

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

856

3929

1.55

30.61

1.5

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

397

1472

1.92

30.60

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1009

4811

1.50

30.25

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

407

1534

1.89

29.89

2.2

1.8

140.7

137.4

0.33

384

1447

(3045716) Anion gap in Serum or Plasma

316

1090

2.06

29.83

2.6

2.4

9.1

9.2

mmol/l

0.24

233

798

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1017

4871

1.49

29.83

1.1

812.2

2658.8

iu/ml

0.42

242

1144

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

537

2206

1.73

29.76

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

537

2206

1.73

29.76

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

537

2206

1.73

29.76

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

564

2358

1.70

29.36

2.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1171

5785

1.44

29.32

3.1

2.1

0.9

0.8

nmol/l

3.70

974

4883

(3010503) CD19 cells [#/volume] in Blood

443

1729

1.82

29.18

2.8

2.6

0.3

e9/l

0.09

430

1688

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

468

1860

1.79

29.06

2.7

3.3

110.2

124.4

nmol/l

0.47

459

1826

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

286

961

2.11

28.92

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1077

5265

1.46

28.51

1.2

1.1

15.1

11.7

au/ml

0.41

380

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

394

1493

1.88

28.49

1.1

7.4

10.9

u/ml

1.18

266

(3000492) Spirometry study

5302

32043

1.19

28.49

1.5

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1264

6378

1.41

28.19

1.1

1.3

1.1

u/ml

0.31

578

2695

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3954

23268

1.22

28.17

2.8

2.5

73.1

68.6

ml/min/173m2

7.78

1562

8847

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

110

229

3.41

28.16

4.0

3.8

2.3

mg/l

0.07

198

(40757494) Bilirubin.total [Moles/volume] in Blood

358

1323

1.92

27.93

2.1

16.3

24.8

umol/l

1.05

129

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

233

732

2.26

27.79

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

110

233

3.35

27.45

2.2

2.1

1.3

umol/l

0.21

209

(3014148) Varicella zoster virus Ab [Titer] in Serum

965

4653

1.48

27.42

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1586

8378

1.35

26.81

2.7

2.6

—

(40768443) Skin Pathology biopsy report

2296

12786

1.28

26.60

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

636

2816

1.61

26.59

3.8

3.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

267

904

2.10

26.54

1.2

16.7

21.1

0.35

165

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

222

698

2.26

26.46

3.1

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

222

698

2.26

26.46

3.1

2.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1103

5495

1.43

26.44

1.3

3.4

3.7

ug/l

0.82

993

4948

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1241

6320

1.40

26.28

1.1

2.3

u/ml

0.03

335

1576

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

370

1412

1.86

26.23

1.5

1.6

16.6

5.5

nmol/l

0.35

298

1178

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

800

3749

1.52

26.11

1.4

346.4

303.9

pmol/l

1.61

630

2937

(3011897) Casein IgE Ab [Units/volume] in Serum

181

523

2.46

26.02

1.1

1.2

9.1

6.8

u/ml

0.13

117

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

259

874

2.11

25.98

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

220

701

2.23

25.43

1.1

6.1

7.2

mg/g

1.53

205

671

(3019977) pH of Arterial blood

347

1311

1.88

25.40

2.8

2.5

7.4

1.51

478

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

300

1079

1.98

25.36

2.1

2.5

1.1

ug/l

0.14

285

1009

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1088

5450

1.42

25.33

1.3

1.2

55.8

152.7

titre

2.74

109

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

759

3541

1.53

25.31

1.1

95.1

96.1

0.43

709

3332

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

220

703

2.22

25.27

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

652

2941

1.58

25.25

1.8

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

282

995

2.01

25.15

2.5

2.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1524

8083

1.35

25.10

5.4

3.7

1.5

1.4

mg/l

1.28

1416

7514

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

566

2472

1.63

25.04

1.4

1.3

1.5

1.4

nmol/l

2.00

519

2227

(3030313) Adrenal Ab [Titer] in Serum

123

296

2.95

25.03

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

773

3639

1.51

24.73

1.6

1.4

—

(3011048) Pyruvate [Moles/volume] in Blood

153

3.80

24.57

1.4

84.8

73.9

umol/l

1.35

138

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

298

1084

1.95

24.42

1.1

93.5

91.5

0.53

137

502

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1069

5375

1.42

24.38

3.6

3.1

—

(4268621)

737

3445

1.52

24.38

2.4

2.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

153

421

2.58

24.34

2.1

2.5

1.2

mmol/l

0.32

148

399

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1838

10074

1.30

24.06

1.7

1.6

3.3

6.5

iu/ml

0.44

388

2055

(3004616) Nuclear Ab [Presence] in Serum

777

3684

1.50

24.04

1.4

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

416

1693

1.75

23.95

2.9

2.7

40.4

39.3

0.38

126

594

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

531

2316

1.63

23.65

1.3

0.6

1.3

u/ml

2.29

235

984

(3047007) Chlamydophila sp Ab [Presence] in Serum

981

4884

1.43

23.65

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

495

2121

1.66

23.63

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

217

710

2.17

23.58

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

566

2513

1.60

23.47

1.2

155.6

204.2

titre

0.79

419

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

290

1061

1.94

23.40

1.1

95.1

92.9

0.39

135

497

(3003694) ABO and Rh group [Type] in Blood

14328

93828

1.11

23.33

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

564

2506

1.60

23.31

1.2

87.1

208.8

titre

2.10

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1978

11004

1.28

23.11

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1977

10998

1.28

23.10

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

440

1845

1.70

22.80

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1966

10948

1.28

22.79

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1971

10980

1.28

22.78

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

654

3024

1.54

22.77

1.2

66.2

65.3

u/l

0.07

456

2051

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

298

1114

1.90

22.59

1.2

1.1

112.1

108.9

0.65

272

1004

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

212

701

2.15

22.47

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

187

587

2.26

22.47

1.1

2.6

7.9

u/ml

1.34

134

407

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

214

713

2.13

22.26

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

402

1658

1.72

22.13

2.4

2.5

722.7

1026.9

u/ml

2.87

397

1641

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

202

661

2.17

21.99

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

2084

11743

1.27

21.96

1.4

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

251

896

1.99

21.76

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

342

1359

1.79

21.42

1.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

212

715

2.11

21.41

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

155

458

2.40

21.35

2.5

2.4

1.2

mmol/l

0.98

150

434

(3044242) Glucose [Moles/volume] in Arterial blood

287

1084

1.88

21.13

2.1

2.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

318

1243

1.82

21.03

2.4

2.3

10.5

10.3

0.07

302

1154

(3000060) B lymphocytes [#/volume] in Blood

254

922

1.96

21.03

2.4

2.2

192.3

364.7

e6/l

1.05

164

480

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

175

551

2.25

20.92

1.5

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

525

2357

1.58

20.85

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

607

2844

1.52

19.97

3.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

653

3108

1.49

19.93

2.8

3.3

6.0

7.3

nmol/l

0.26

624

3015

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

294

1143

1.83

19.82

1.1

—

(3022621) pH of Urine by Test strip

3225

19241

1.20

19.77

3.1

2.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

468

2072

1.61

19.73

1.1

ratio

0.03

142

753

(3012494) Peanut IgE Ab [Units/volume] in Serum

263

994

1.88

19.38

1.1

1.7

17.9

u/ml

0.95

161

554

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

308

1224

1.79

19.35

1.5

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

885

4489

1.40

19.31

1.5

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

115

309

2.64

19.28

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

291

1140

1.81

19.17

2.2

1.9

152.6

162.3

0.84

280

1072

(3014051) Protein [Presence] in Urine by Test strip

1221

6528

1.33

19.15

2.2

2.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

270

2.76

19.13

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1638

9118

1.28

19.09

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

307

1224

1.78

19.09

1.5

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

116

315

2.61

19.06

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

305

1216

1.78

18.97

2.3

2.2

28.9

29.4

0.26

294

1152

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

166

538

2.19

18.59

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

616

2944

1.49

18.48

3.9

4.8

80.9

110.0

u/ml

0.59

168

926

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2888

17165

1.20

18.43

3.1

3.2

50.7

47.9

u/ml

0.10

2773

16596

(3004809) Band form neutrophils/100 leukocytes in Blood

850

4324

1.40

18.27

3.0

3.2

1.3

1.5

0.53

669

3339

(3050129) First trimester maternal screen panel - Serum or Plasma

2417

14134

1.22

18.23

1.5

1.4

—

(3028433) Virus identified in Specimen by Culture

249

946

1.87

18.10

1.2

—

(40768800) Prostate Pathology biopsy report

370

4199

0.62

17.82

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

792

3998

1.41

17.81

2.5

2.9

1310.1

313.0

u/ml

0.39

745

3798

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

6243

39508

1.14

17.73

1.5

1.4

—

(3017569) Oxygen content in Arterial blood

272

1070

1.81

17.72

2.0

2.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

427

1900

1.60

17.70

1.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

283

1131

1.78

17.51

3.1

2.8

—

(3005033) Fetal Nuchal fold Thickness US

1588

8911

1.27

17.37

1.4

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

365

1570

1.65

17.34

1.0

257.1

342.8

ng/l

2.96

279

1124

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

503

2338

1.53

17.26

3.9

4.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

367

1584

1.65

17.21

1.0

35.1

42.4

ng/l

2.58

278

1108

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

324

1355

1.70

17.12

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

329

1382

1.69

17.10

2.3

2.2

20.8

162.0

ug/l

1.90

314

1320

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

366

1582

1.64

17.07

1.0

841.4

738.6

ng/l

3.78

272

1088

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

322

1346

1.70

17.04

2.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

322

1346

1.70

17.04

2.0

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

322

1346

1.70

17.04

2.0

1.9

—

(3016228) CD19 cells/100 cells in Blood

286

1158

1.75

16.95

2.1

2.0

8.7

8.5

0.15

278

1133

(3035320) C reactive protein [Mass/volume] in Body fluid

468

2150

1.55

16.94

3.0

2.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

322

1351

1.69

16.82

2.0

1.9

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

461

2116

1.55

16.76

1.1

6.9

8.2

iu/ml

0.63

575

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1585

8932

1.27

16.76

1.4

1.5

—

(3023419) Bacteria identified in Sputum by Culture

641

3150

1.45

16.74

2.7

2.5

—

(3032057) Clostridioides difficile [Presence] in Stool

155

511

2.15

16.71

1.9

1.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

287

1169

1.74

16.67

1.1

134.3

606.3

ng/l

1.96

266

(3039000) Anion gap in Blood

1094

5879

1.33

16.63

7.7

6.6

11.2

mmol/l

0.03

994

5270

(3018572) Chloride [Moles/volume] in Blood

1094

5880

1.32

16.61

7.8

6.6

105.0

105.2

mmol/l

0.31

994

5272

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

163

551

2.10

16.50

1.3

1.5

5.7

5.6

nmol/l

0.14

154

527

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

379

1669

1.61

16.44

1.2

21.7

23.4

u/l

0.27

326

1442

(3008116) Ketones [Moles/volume] in Urine by Test strip

163

553

2.09

16.36

1.6

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1049

5619

1.33

16.31

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

279

1135

1.75

16.29

2.1

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

354

1542

1.63

16.06

1.6

1.2

1.3

nmol/l

0.28

259

1243

(3042733) HLA Ab [Presence] in Serum

272

1108

1.74

15.83

4.3

5.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1019

5461

1.33

15.81

1.1

4.3

4.6

u/ml

0.17

427

2163

(3024869) Neuronal Ab [Presence] in Serum

137

440

2.21

15.77

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

385

1720

1.59

15.76

1.2

91.4

87.5

u/l

0.25

338

1510

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

258

2.61

15.70

1.6

1.7

1.4

1.9

mg/l

0.48

169

(3010375) cycloSPORINE [Mass/volume] in Blood

319

1361

1.66

15.70

28.2

27.2

126.7

117.1

ug/l

0.78

260

1131

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

262

1059

1.76

15.67

2.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

370

1642

1.60

15.58

1.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

139

453

2.18

15.46

1.1

1.0

85.8

80.4

ug/l

0.72

119

372

(3041806) Other cells [#/volume] in Blood by Manual count

365

1618

1.60

15.45

1.5

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

257

1041

1.75

15.27

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

257

1041

1.75

15.27

2.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

101

288

2.49

15.16

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

430

1990

1.54

15.13

1.6

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

323

1397

1.64

15.10

1.2

1.1

3.5

4.0

iu/ml

0.53

108

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

157

542

2.06

15.10

1.4

1.5

0.3

0.2

nmol/l

0.36

116

398

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

155

533

2.06

15.06

1.3

—

(3049717) Cytology report of Urine Cyto stain

1523

8655

1.25

15.03

2.3

2.6

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

252

2.59

14.98

1.6

3.2

4.3

mg/l

0.90

162

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

252

2.59

14.98

1.6

1.9

2.2

mg/l

0.16

167

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

252

2.59

14.98

1.6

0.9

mg/l

0.07

168

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

252

2.59

14.98

1.6

2.2

mg/l

0.47

185

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

252

2.59

14.98

1.6

2.7

2.3

mg/l

0.27

175

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

252

2.59

14.98

1.6

2.3

1.7

mg/l

0.48

153

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

252

2.59

14.98

1.6

2.9

mg/l

0.00

183

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

252

2.59

14.98

1.6

1.8

mg/l

0.32

177

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

252

2.59

14.98

1.6

1.0

1.5

mg/l

0.70

155

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

143

478

2.12

14.95

1.2

1.1

—

(3014271) Vancomycin [Susceptibility]

262

1074

1.73

14.95

3.2

2.8

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

191

711

1.91

14.88

1.3

1.2

108.7

107.9

0.12

182

669

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

230

911

1.79

14.76

3.4

3.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1464

8303

1.26

14.71

3.9

3.2

0.3

0.4

u/ml

2.15

851

4666

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

361

1619

1.58

14.59

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

340

1506

1.60

14.48

9.4

5.5

593.5

3615.3

u/ml

0.69

117

274

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

116

361

2.28

14.43

1.3

50.8

53.3

0.18

182

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

106

317

2.37

14.41

1.0

0.8

2.1

u/ml

0.73

235

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

212

2.71

14.41

1.4

7.8

14.5

pmol/l

1.46

178

(3006270) Folate [Moles/volume] in Blood

469

2240

1.49

14.25

1.2

1.1

380.3

381.3

nmol/l

0.04

413

1939

(3045462) Protein/Creatinine [Ratio] in Urine

289

2.43

14.18

5.1

5.3

59.3

51.8

g/mol

0.12

259

(3002256) Pathology report gross observation

6074

38869

1.12

14.17

1.2

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

183

684

1.90

14.12

1.1

1.2

89.3

89.0

0.03

188

(3033923) Metanephrine [Moles/time] in 24 hour Urine

162

582

1.98

14.02

1.1

0.7

3.2

umol/24h

0.53

298

(3027231) Wheat IgE Ab [Units/volume] in Serum

183

686

1.89

14.00

1.1

1.0

1.3

2.1

u/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

385

1771

1.54

13.97

1.7

1.6

4.0

6.8

u/l

3.97

181

881

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

406

1894

1.52

13.82

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

155

551

2.00

13.82

6.2

5.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1024

5600

1.30

13.81

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

947

5127

1.31

13.75

1.1

6.7

4.9

u/ml

1.07

426

2143

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

220

880

1.77

13.71

2.1

1.9

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.68

13.69

5.7

4.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3485

21565

1.16

13.65

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

488

2371

1.46

13.64

1.3

1.2

56.4

48.1

u/ml

0.18

108

(3001964) Herpes simplex virus Ag [Presence] in Specimen

222

893

1.76

13.58

1.8

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

239

988

1.72

13.31

2.1

1.6

46454.3

22556.0

u/ml

0.26

107

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

262

1112

1.67

13.25

1.0

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

223

2.58

13.12

1.2

18.8

14.7

nmol/l

0.80

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

104

3.41

13.05

4.2

2.7

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

104

323

2.28

13.05

1.0

1.5

1.3

u/ml

0.06

240

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

343

1563

1.56

13.01

1.2

1.3

—

(3042631) Mycobacterium sp identified in Specimen

645

3325

1.38

12.98

2.8

2.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

380

1773

1.52

12.97

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1183

6646

1.27

12.94

1.7

1.6

14349.1

12418.8

e6/l

0.58

834

4881

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

297

1311

1.61

12.90

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

474

2318

1.45

12.84

1.3

1.2

62.5

42.5

u/ml

0.87

179

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

137

479

2.03

12.82

1.6

1.3

759.4

103.7

ng/l

0.44

319

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

473

2313

1.45

12.82

1.3

1.2

68.0

67.7

u/ml

0.01

110

(3017354) Segmented neutrophils/100 leukocytes in Blood

526

2632

1.42

12.61

3.0

3.2

58.0

58.2

0.07

344

1693

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

151

2.91

12.60

1.2

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

277

1211

1.62

12.52

5.2

5.4

67.6

3476.0

mg/l

5.35

205

865

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

100

3.40

12.51

3.9

2.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

305

1366

1.59

12.49

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

331

1513

1.55

12.42

1.1

97.4

97.5

0.02

265

1206

(3024932) HLA-DR beta [Type]

251

1074

1.66

12.35

1.1

—

(3024471) HLA-A [Type]

255

1096

1.65

12.33

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

342

1583

1.53

12.14

1.1

1663.0

1474.0

miu/ml

2.18

342

1583

(40768441) Liver Pathology biopsy report

446

2181

1.45

12.12

1.5

1.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

100

316

2.24

12.09

2.5

3.4

42.4

umol/l

0.01

266

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.90

11.99

1.2

1.0

—

mmol/l

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

176

688

1.82

11.91

1.1

72.2

77.7

0.62

178

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1273

7286

1.24

11.89

3.2

3.3

1.5

3.7

ratio

1.42

123

551

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

343

1598

1.52

11.84

1.2

10.9

13.6

u/ml

0.17

154

(3034860) Kappa light chains.free [Mass/volume] in Serum

1308

7513

1.24

11.83

3.3

3.4

46.4

63.4

mg/l

0.94

1054

6069

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

451

2222

1.44

11.80

1.3

1.2

13.2

9.4

u/ml

0.25

153

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1305

7502

1.24

11.71

3.3

3.4

30.8

43.1

mg/l

4.40

1044

6068

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

109

363

2.13

11.63

1.3

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

159

607

1.86

11.61

1.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

128

455

2.00

11.51

1.1

0.2

0.3

u/ml

0.22

282

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

251

1095

1.63

11.49

1.1

1.0

7.5

12.3

u/ml

1.48

145

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

888

4892

1.29

11.42

1.1

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

504

2557

1.40

11.23

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

973

5440

1.27

11.14

1.6

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

125

447

1.98

11.08

2.3

2.5

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

200

2.52

11.06

1.0

0.2

2.2

u/ml

1.76

158

(3045683) HLA typing for celiac disease panel - Blood or Tissue

433

2147

1.43

10.99

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

205

2.49

10.98

1.1

1.6

3.1

u/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

173

691

1.78

10.95

1.2

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.75

10.81

1.0

0.4

0.6

u/ml

0.40

(3000330) Specific gravity of Urine by Test strip

2222

13538

1.17

10.72

3.5

3.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

120

430

1.98

10.60

1.7

1.6

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

583

5509

0.75

10.56

3.3

2.4

13.2

13.1

0.67

578

5438

(3006442) Creatine [Moles/volume] in Serum or Plasma

427

2132

1.42

10.46

1.8

1.4

60.4

71.8

umol/l

3.46

185

(3002619) Bacteria identified in Specimen by Culture

147

567

1.84

10.45

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

238

1052

1.61

10.39

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

165

666

1.76

10.13

1.3

1.2

401.2

318.1

pmol/l

0.78

115

493

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

304

1430

1.51

10.12

3.5

3.2

7.9

8.2

mg/l

0.33

251

1138

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

163

2.61

10.08

1.7

1.6

198.8

165.9

ug/g

0.60

143

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

295

1381

1.52

10.05

1.2

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.77

10.00

2.2

2.9

—

(3044941) Cell count panel - Synovial fluid

780

4304

1.29

9.98

1.5

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

138

530

1.85

9.97

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

685

3719

1.31

9.90

1.2

1.1

2.0

iu/ml

—

(4034850)

1594

9515

1.19

9.84

11.1

8.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

316

1508

1.49

9.83

1.4

1.3

439.5

441.8

titre

0.00

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

797

4421

1.28

9.79

1.1

1.0

0.4

0.5

u/ml

0.52

187

922

(3010370) Gastrin [Moles/volume] in Serum or Plasma

120

443

1.92

9.78

1.7

1.8

72.8

50.6

pmol/l

0.27

104

375

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

244

2.27

9.75

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

133

509

1.85

9.73

2.5

2.7

31.6

47.9

mg/l

0.65

(4024509)

498

2587

1.37

9.71

1.7

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

157

633

1.76

9.70

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

306

2.11

9.57

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

251

2.23

9.54

2.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

307

1467

1.49

9.51

1.4

1.3

62.6

79.6

titre

0.40

118

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

914

5175

1.26

9.50

1.1

2.8

u/ml

0.10

350

2686

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

169

2.52

9.41

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

103

366

2.00

9.37

1.0

0.1

0.2

u/ml

1.04

219

(3034426) Prothrombin time (PT)

246

1125

1.55

9.36

1.3

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

174

2.49

9.33

1.5

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

170

2.50

9.31

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

196

2.39

9.28

3.9

2.2

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

3.54

9.21

1.1

298.5

417.8

pmol/l

0.50

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

604

3261

1.32

9.14

1.1

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

145

582

1.77

9.12

1.4

1.3

107.0

72.6

mu/l

0.31

114

433

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

303

2.08

9.09

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1244

7313

1.21

9.09

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

228

1034

1.56

9.02

2.7

2.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

169

2.48

8.97

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1235

7271

1.21

8.89

1.3

1.2

—

(44806071)

112

418

1.90

8.88

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

276

1310

1.50

8.88

2.9

2.7

135.0

155.3

au/ml

0.30

177

(3028717) Thiamine [Mass/volume] in Blood

297

2.08

8.84

1.2

—

(3021788) Differential panel - Synovial fluid

903

5151

1.25

8.83

1.6

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

188

2.38

8.79

2.1

1.7

49.0

46.2

umol/l

0.25

188

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

193

2.35

8.73

1.0

0.3

0.7

u/ml

1.04

177

(40760888) Immunoglobulin light chains.free panel - Serum

982

5660

1.23

8.73

3.2

3.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

299

1448

1.47

8.71

1.2

1.1

96.9

83.1

u/l

1.09

237

1167

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

299

1449

1.46

8.68

1.2

1.1

34.2

23.0

u/l

1.01

222

1133

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

107

397

1.91

8.65

1.4

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

344

1714

1.42

8.63

1.5

24.9

23.4

u/ml

0.19

317

(3008037) Lactate [Moles/volume] in Venous blood

932

5350

1.24

8.62

3.4

3.0

1.5

mmol/l

0.59

914

5228

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1980

12169

1.16

8.60

1.5

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1296

7699

1.20

8.50

1.5

1.4

122.1

124.0

pmol/l

0.05

1262

7506

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

200

2.30

8.50

1.5

34.7

37.8

0.22

136

(3033942) Copper [Moles/time] in 24 hour Urine

136

2.61

8.45

1.2

0.9

0.8

umol/24h

0.05

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

108

406

1.89

8.41

2.4

2.0

—

(3044927) Protein electrophoresis panel - Urine

434

2260

1.36

8.41

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

248

1165

1.51

8.41

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

215

2.24

8.36

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

184

2.35

8.34

1.5

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

198

886

1.59

8.33

5.8

6.4

25.1

mmol/l

0.05

185

805

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

296

2.04

8.23

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

151

2.49

8.18

1.1

1.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

329

1647

1.42

8.08

1.5

1.4

11.8

12.5

u/l

1.22

319

1595

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

285

1390

1.46

8.05

1.1

—

(3013762) Body weight Measured

111

2.75

8.03

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

275

2.06

8.03

1.1

1.0

—

(3045424) Erythrocytes [Presence] in Urine

900

5190

1.23

8.01

1.6

1.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

418

2185

1.36

7.94

1.4

28.8

32.2

nmol/l

1.56

374

2015

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

351

1.92

7.82

1.0

0.6

0.8

u/ml

0.13

188

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

117

2.67

7.79

1.5

1.6

0.0

0.1

u/l

1.02

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

177

2.32

7.76

1.5

10.9

13.7

0.46

130

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

119

475

1.78

7.71

1.7

1.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.69

7.70

1.9

2.6

2.0

2.3

mu/l

0.13

(3016031) Almond IgE Ab [Units/volume] in Serum

228

2.15

7.67

1.0

0.4

0.7

u/ml

0.71

131

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

110

2.71

7.65

1.1

469.8

438.4

u/l

0.06

(3036603) Volume of Urine

373

1927

1.37

7.65

1.5

1.7

1772.7

1961.5

1.00

438

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

566

3110

1.29

7.61

1.1

—

(3020491) Glucose [Moles/volume] in Blood

429

2270

1.34

7.55

1.7

6.7

6.6

mmol/l

0.30

329

1689

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

361

1.89

7.52

1.0

0.9

3.3

u/ml

0.68

188

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

189

2.25

7.49

1.3

1.2

5.7

5.1

u/ml

0.05

154

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

164

1816

0.64

7.42

1.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

579

3203

1.28

7.41

2.1

32.4

32.6

0.52

572

3179

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

117

472

1.76

7.34

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

231

1104

1.48

7.29

4.1

3.9

—

(3016750) Collection duration of Urine

304

1532

1.41

7.25

2.3

2.2

519.8

496.6

min

4.14

232

1168

(3037756) Immunofixation for Serum or Plasma

852

4955

1.22

7.06

1.8

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

314

1.92

7.05

1.3

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

344

1.88

7.05

2.7

2.5

1.0

1.4

mmol/l

1.02

244

(3051339) Copper [Moles/volume] in Blood

150

2.36

6.99

1.2

1.3

16.0

16.7

umol/l

0.46

131

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

192

2.18

6.86

1.0

1.1

7.6

10.1

u/l

0.74

192

(21491868) Cryoglobulin [Mass/volume] in Serum

218

1044

1.48

6.84

1.3

1.2

0.6

0.5

g/l

—

(4015189)

148

650

1.62

6.82

2.5

2.3

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

184

2.20

6.76

1.1

1.2

22.7

17.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

277

1392

1.41

6.75

1.6

1.5

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.11

6.75

1.6

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

231

2.06

6.74

1.2

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

4.93

6.69

1.2

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

306

1568

1.38

6.67

1.6

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

573

3212

1.27

6.65

1.4

11.8

mmol/l

0.01

183

664

(40768446) Kidney Pathology biopsy report

257

1279

1.43

6.62

2.0

1.7

—

(4035726)

3870

25156

1.10

6.61

1.5

1.4

—

(3018133) Calcium [Moles/volume] in Urine

123

520

1.68

6.59

2.0

2.1

2.6

2.7

mmol/l

0.19

113

467

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

273

1.95

6.53

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

278

1407

1.40

6.52

1.6

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

479

2635

1.29

6.47

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

119

507

1.66

6.22

1.2

1.3

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

150

2.27

6.17

1.4

1.3

1.5

1.4

0.05

101

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

301

1560

1.37

6.16

1.8

1.7

2.3

2.4

u/field

0.08

212

1139

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

3.22

6.15

1.0

0.0

0.1

u/ml

0.28

(40763480) Human metapneumovirus Ag [Presence] in Specimen

124

2.40

6.12

1.5

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

146

659

1.57

6.07

1.6

1.5

0.4

ug/l

0.19

445

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

138

2.31

6.04

1.0

0.2

0.1

u/ml

0.22

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

103

426

1.71

6.02

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

226

1120

1.43

6.01

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

429

2353

1.29

5.97

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

554

3138

1.25

5.94

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

204

995

1.45

5.91

1.7

137.3

138.2

au/ml

0.01

129

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

392

1.74

5.88

1.7

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

366

1.76

5.87

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

207

1014

1.45

5.87

5.4

9.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

248

1256

1.40

5.85

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

178

848

1.49

5.81

1.6

9.4

8.9

ug/l

0.73

178

848

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

221

1.99

5.77

1.1

38.6

31.5

u/ml

0.16

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

221

1.99

5.77

1.1

24.1

26.0

u/ml

0.11

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

242

1224

1.40

5.76

3.0

3.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

444

2461

1.28

5.72

1.9

1.7

—

(4146454)

488

2738

1.27

5.70

2.7

2.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

375

1.74

5.68

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

105

445

1.67

5.64

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

193

942

1.45

5.60

1.8

1.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.65

5.51

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

100

2.48

5.49

1.0

1.1

0.2

g/l

2.93

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

173

2.09

5.43

1.1

1.0

—

(3017400) Magnesium [Moles/volume] in Urine

3.04

5.42

1.2

1.1

3.2

3.0

mmol/l

0.08

(3022229) Phosphate [Moles/volume] in Urine

178

2.07

5.41

1.8

2.2

21.1

19.8

mmol/l

0.18

151

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

334

1.76

5.38

1.0

0.1

0.6

u/ml

1.71

184

(3038515) Glucose [Moles/volume] in Venous blood

841

5026

1.19

5.35

3.6

3.0

7.2

7.5

mmol/l

1.24

826

4930

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

244

1254

1.38

5.33

2.1

2.0

8.7

9.5

mg/l

1.37

192

1004

(3020876) Protein [Mass/time] in 24 hour Urine

397

2196

1.28

5.24

2.1

2.0

0.8

1.1

g/24h

0.39

139

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.49

5.22

1.1

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

126

572

1.56

5.18

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

699

4123

1.20

5.15

1.3

1.2

33.2

32.6

u/l

0.03

612

3605

(3004451) EKG impression Narrative

233

1196

1.38

5.14

1.4

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

168

2.07

5.10

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

237

1.88

5.08

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

309

1.77

5.06

1.2

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

299

1.78

5.04

1.2

1.1

1.6

3.0

umol/24h

0.61

299

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

417

1.65

5.00

1.3

1.5

98555.8

239893.6

nmol/l

0.56

351

(3012898) Urea [Moles/volume] in Urine

290

1.78

4.97

1.6

1.5

161.7

173.1

mmol/l

0.34

260

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.22

4.96

1.1

1.2

—

(3049233) Organic acids panel - Urine

3.78

4.95

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

185

1.99

4.92

1.1

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

395

2207

1.27

4.85

2.0

1.9

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

249

2354

0.75

4.82

1.2

1.3

1.4

1.5

g/l

0.67

111

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

242

1.85

4.79

1.0

0.1

1.1

u/ml

1.28

150

(3020874) Milk IgE Ab [Units/volume] in Serum

415

2340

1.26

4.73

1.1

3.2

2.4

u/ml

0.16

142

653

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

159

776

1.45

4.69

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

113

514

1.56

4.66

1.9

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1042

6416

1.15

4.62

2.5

2.4

123.8

104.1

ug/min

0.55

626

3886

(3002523) Influenza virus A Ag [Presence] in Specimen

979

6001

1.16

4.62

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

114

2.24

4.58

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4083

27035

1.08

4.53

3.5

4.0

19.7

23.8

ug/l

0.46

3200

21310

(3006462) Nitrate [Presence] in Urine

266

1425

1.32

4.52

3.3

2.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

155

759

1.45

4.52

1.4

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

100

446

1.59

4.50

5.2

47.1

46.0

ug/min

0.05

346

(3003740) Influenza virus B Ag [Presence] in Specimen

977

6004

1.16

4.47

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

398

1.62

4.43

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

100

448

1.58

4.42

2.8

2.3

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

229

1.83

4.38

1.4

1.3

1.6

ml/s/173m2

0.29

151

(4094501)

1270

7959

1.13

4.37

1.1

—

(3024263) Appearance of Synovial fluid

263

1415

1.32

4.35

1.9

1.8

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.45

4.35

1.2

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.49

4.31

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

269

1455

1.31

4.30

1.6

4.7

5.8

mmol/24h

0.88

117

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

109

2.21

4.23

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

210

1099

1.36

4.20

1.1

—

(36303858) Crystals [Presence] in Urine

3.34

4.20

1.2

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

215

1130

1.35

4.19

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

182

1.91

4.17

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

276

1.72

4.11

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

214

1.82

4.08

2.9

94.9

400.2

pmol/l

0.43

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

340

1910

1.26

4.07

2.1

1.7

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.29

4.04

1.0

297.1

187.6

pmol/l

0.58

(3032352) Blasts [#/volume] in Cerebral spinal fluid

283

1.70

4.03

3.0

2.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

111

522

1.51

4.00

2.2

5.3

74.9

52.2

u/l

0.33

206

(3044009) aPTT.lupus sensitive (LA screen)

300

1.68

3.99

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

103

2.20

3.96

1.0

1.1

2.1

1.0

u/field

0.43

(3036312) Salmon IgE Ab [Units/volume] in Serum

206

1.82

3.95

1.1

1.6

1.3

u/ml

0.13

145

(3008536) Aspergillus sp Ab [Presence] in Serum

117

558

1.49

3.95

2.1

2.3

—

(3007916) DNA double strand Ab [Titer] in Serum

390

1.58

3.89

1.3

115.5

154.6

titre

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

208

1.81

3.84

2.5

3.1

23.8

10.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.73

3.83

1.2

1.1

1.8

2.7

1.21

(4211845)

284

1575

1.28

3.81

3.2

2.8

—

(40768793) Breast Pathology biopsy report

1129

7093

1.13

3.80

1.3

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

209

1.80

3.79

1.0

21.9

18.1

u/ml

0.15

170

(3004775) Volume in Urine collected for unspecified duration

359

2051

1.24

3.75

2.4

2.3

689.9

675.3

0.28

272

1426

(3003129) Base excess in Capillary blood by calculation

130

648

1.42

3.54

1.6

1.7

0.9

0.6

mmol/l

0.43

121

612

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

344

1.59

3.53

1.1

1.5

—

69.5

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.28

3.50

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

2.23

3.46

1.4

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

848

5271

1.14

3.41

1.2

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

165

1.85

3.39

1.1

1.4

1.1

u/field

0.63

116

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

207

1.75

3.36

1.1

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

137

697

1.39

3.35

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

137

697

1.39

3.35

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

137

697

1.39

3.35

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

137

697

1.39

3.35

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

149

770

1.37

3.32

1.9

1.6

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

142

729

1.38

3.30

1.8

1.9

42.4

36.1

u/l

0.19

125

657

(3013293) Extractable nuclear Ab [Presence] in Serum

471

1.48

3.26

1.7

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

460

1.48

3.25

4.0

6.3

68.6

69.7

0.15

360

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.54

3.23

1.1

1.4

79.0

50.7

e6/l

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1474

9497

1.10

3.21

3.0

3.6

4629.7

1366.6

u/ml

0.36

1237

8153

(3033705) Calcium.ionized [Moles/volume] in Venous blood

482

2888

1.18

3.17

2.7

2.3

—

(37019676) Renin [Units/volume] in Plasma --supine

2.44

3.15

1.1

1.0

73.4

59.3

mu/l

0.10

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

159

1.83

3.15

1.0

1.1

38.5

52.5

u/l

1.45

126

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

227

1258

1.28

3.14

1.5

1.6

—

(3013466) aPTT in Blood by Coagulation assay

207

1.71

3.10

1.1

34.8

36.7

1.70

176

(40762365) Oxygen content in Arterial blood by calculation

419

1.49

3.09

3.0

14.9

ml/dl

0.03

390

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

226

1258

1.27

3.04

1.5

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

294

1688

1.24

3.03

1.9

1.8

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

198

1.72

3.03

1.3

1.4

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.33

3.00

1.0

2.3

0.4

u/ml

0.38

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.08

2.99

1.0

1.1

194.4

278.3

nmol/l

2.08

(3044590) Delta aminolevulinate [Moles/volume] in Urine

4.56

2.97

1.1

1.0

18.6

13.3

umol/l

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

390

2312

1.20

2.93

1.1

1.0

3.2

3.7

u/ml

0.09

114

569

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.20

2.92

4.3

5.6

8.1

6.2

mg/l

0.26

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

143

1.83

2.90

1.2

1.3

1430.5

1103.5

u/l

0.08

125

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

466

1.45

2.90

1.1

2.8

7.4

pmol/l

0.63

(3012989) Citrate [Moles/time] in 24 hour Urine

2.32

2.86

1.6

1.4

1.9

2.3

mmol/24h

0.60

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

129

1.87

2.82

1.0

0.2

0.1

u/ml

0.47

(3017704) Immunofixation for Urine

232

1309

1.26

2.82

1.8

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

431

2588

1.18

2.82

1.4

67666.7

106998.9

e6/l

0.99

312

1761

(3019768) Coxiella burnetii Ab [Presence] in Serum

171

1.74

2.80

1.3

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

225

1268

1.26

2.77

2.1

58.6

107.9

ug/min

0.86

289

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

247

1412

1.24

2.70

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

444

2684

1.17

2.70

1.6

1.5

30.9

33.2

0.62

283

1663

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

100

503

1.41

2.69

2.2

2.4

6.8

7.5

mmol/l

1.32

294

(3032641) Amino acids panel - Urine

2.79

2.64

1.2

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

830

5250

1.12

2.63

3.2

3.4

383.4

916.5

u/ml

1.67

741

4779

(3022475) Manganese [Moles/volume] in Blood

196

1.66

2.63

1.2

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

418

2522

1.18

2.61

3.0

62.3

53.6

mg/l

0.25

288

1797

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.09

2.61

1.0

—

(3024316) Viscosity of Plasma

133

1.81

2.60

1.6

1.5

mpas

0.01

(3019174) dRVVT (LA screen)

292

1.53

2.57

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

392

1.45

2.51

2.0

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.93

2.50

1.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

375

1.46

2.49

3.1

2.8

23.1

23.2

mg/l

0.02

353

(21494890) Protein electrophoresis panel - 24 hour Urine

415

2514

1.17

2.49

2.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.94

2.44

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

147

1.74

2.41

8.5

9.8

632.3

207.3

e6/l

0.55

101

(3045177) Copper [Moles/volume] in Urine

2.36

2.40

1.0

1.1

0.2

0.5

umol/l

—

(36304079) Mucus [Presence] in Urine sediment

4.51

2.39

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

364

2190

1.18

2.39

2.0

1.9

2.2

u/field

0.09

184

998

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

165

1.68

2.32

1.1

1.2

—

510.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

393

1.42

2.31

2.7

61.7

72.4

pmol/l

0.26

338

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

113

1.82

2.28

2.0

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.23

2.27

1.1

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

389

1.42

2.26

1.7

1.6

1.7

mg/l

0.34

329

(3015350) Toxocara sp Ab [Presence] in Serum

2.66

2.26

1.1

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

290

1.49

2.25

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

144

791

1.29

2.25

2.1

2.5

103.9

109.3

ng/l

0.17

435

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.96

2.25

1.0

0.0

0.1

u/ml

0.67

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1096

7101

1.10

2.25

1.9

1.7

—

(3042628) Porphyrins [Moles/volume] in Urine

4.13

2.24

1.1

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.27

2.22

1.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.27

2.22

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

179

1013

1.25

2.21

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

321

1927

1.18

2.20

6.6

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

229

1.55

2.20

1.0

1.1

12.7

8.2

u/ml

0.56

163

(40762887) Creatinine [Moles/volume] in Blood

2.19

2.18

1.2

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.31

2.17

3.0

4.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

105

1.82

2.15

1.3

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

204

1176

1.23

2.14

2.7

3.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

470

2913

1.14

2.13

1.9

2.0

23.8

24.8

ug/l

0.11

460

2851

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

138

761

1.29

2.12

1.1

1.2

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.36

2.12

1.0

0.1

0.2

u/ml

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

123

668

1.31

2.12

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

123

669

1.30

2.10

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

123

670

1.30

2.08

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

257

1.49

2.02

1.2

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

147

823

1.27

2.02

1.4

55.2

52.5

0.36

125

706

(3027570) Oxalate [Moles/time] in 24 hour Urine

195

1.56

2.00

1.7

1.4

347.3

315.4

umol/24h

0.47

195

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

3.54

1.97

1.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

3.54

1.97

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

114

1.74

1.95

11.5

8.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

174

1.59

1.94

3.8

5.6

—

(3035933) Granulocytes/100 leukocytes in Blood

168

961

1.24

1.93

2.5

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

113

616

1.30

1.93

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

138

774

1.26

1.89

1.3

1.2

39.1

40.1

g/l

0.40

418

(3036005) Urine sediment comments by Light microscopy Narrative

2.51

1.89

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.10

1.89

1.0

1.1

108.1

95.4

nmol/24h

0.19

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.83

1.88

3.0

3.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

170

1.58

1.88

1.1

1.0

3.2

2.7

u/l

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.77

1.88

1.1

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

997

6496

1.09

1.87

4.6

3.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

490

1.33

1.86

1.2

1.4

39.8

165.3

titre

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

343

2104

1.16

1.85

1.1

1.0

0.7

u/ml

0.06

277

(3011335) Digoxin [Mass/volume] in Serum or Plasma

189

0.49

1.85

2.5

2.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

369

1.38

1.85

3.3

2.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

425

1.35

1.81

1.3

—

(3000219) Insulin receptor Ab [Presence] in Serum

4.43

1.80

1.0

—

(3000285) Sodium [Moles/volume] in Blood

312

1.41

1.78

1.3

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

384

1.37

1.78

2.2

2.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

259

1.45

1.78

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1847

13875

0.94

1.77

2.0

1.9

—

(3000012) Reticulocyte production index

234

1398

1.19

1.77

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

173

1485

0.82

1.74

2.0

4.0

3.5

ug/l

0.19

145

1320

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

211

0.54

1.71

1.2

1.3

—

(3012565) Volume of 24 hour Urine

248

1496

1.18

1.69

2.2

1949.6

2013.7

0.35

227

1350

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

341

2110

1.15

1.67

1.9

3.6

mg/l

0.01

317

2022

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

110

613

1.27

1.64

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

265

1.42

1.61

1.4

1.2

178.5

321.2

mg/24h

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.29

1.59

1.0

—

(3025577) Chromium [Mass/volume] in Blood

170

1444

0.83

1.56

2.1

2.5

2.4

ug/l

0.13

138

1218

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.82

1.56

8.8

8.3

—

(3010937) Rubella virus Ab [Presence] in Serum

220

1.45

1.54

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

3.04

1.53

1.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

3.04

1.53

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

210

1.45

1.49

1.2

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.13

1.49

1.9

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.13

1.49

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.13

1.49

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.13

1.49

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.13

1.49

2.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.13

1.49

1.6

1.3

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.13

1.49

1.0

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.85

1.48

9.6

8.1

48.8

41.6

0.48

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.77

1.45

1.1

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

103

1.65

1.45

1.0

0.1

0.2

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

295

1.37

1.45

1.3

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

107

606

1.25

1.43

1.3

1.2

43.3

55.1

mg/l

0.10

439

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.83

1.43

1.0

55.0

22.0

umol/l

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

254

1.40

1.42

1.3

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.75

1.40

1.2

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.28

1.39

1.3

1.5

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.65

1.38

1.2

1.1

0.1

g/l

0.46

(3032743) Legionella sp IgG Ab [Presence] in Serum

202

1.44

1.38

1.2

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.73

1.35

1.1

1.0

0.1

0.2

u/ml

0.47

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

233

1.40

1.34

1.1

24.8

21.2

u/l

0.37

157

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

186

1122

1.18

1.34

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

758

4971

1.08

1.32

3.8

3.5

33.1

37.9

u/ml

0.56

721

4800

(3018001) Oat IgE Ab [Units/volume] in Serum

246

1.38

1.32

1.0

0.1

1.0

u/ml

0.71

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

129

1.54

1.30

1.1

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.70

1.30

1.1

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.65

1.29

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

339

2147

1.12

1.24

1.3

6.3

mmol/l

0.01

309

1987

(40761995) Spermatozoa Progressive [#/volume] in Semen

126

1070

0.83

1.22

3.5

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

126

1069

0.83

1.21

7.0

6.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

553

3596

1.09

1.21

1.6

53.8

55.2

0.36

346

2298

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

1.19

0.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

194

1189

1.16

1.18

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

438

1.26

1.17

11.4

6.7

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

332

1.30

1.17

1.2

1.3

1.9

1.4

mmol/l

0.21

214

(3034891) Synovial lining cells/100 cells in Synovial fluid

229

1424

1.14

1.5

5.3

3.7

0.56

326

(3023199) Leukocytes [#/volume] in Pleural fluid

409

2632

1.10

1.14

1.5

1.4

4106.1

3537.5

e6/l

0.21

311

1880

(3002079) Sodium [Moles/time] in 24 hour Urine

1.95

1.13

1.1

149.1

136.1

mmol/24h

0.40

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

111

1.53

1.12

1.1

1.3

1.4

1.1

u/field

—

(3029612) Listeria sp Ab [Titer] in Serum

1.67

1.11

1.6

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

200

1.38

1.10

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

188

1.39

1.10

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

147

1.45

1.08

3.8

3.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

343

1.28

1.07

2.4

2.3

0.6

0.7

u/field

0.38

343

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

142

1.45

1.06

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.57

1.06

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1358

10096

0.95

1.02

1.8

—

(3011325) HIV 1+2 Ab [Presence] in Serum

161

1.41

1.02

1.1

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

261

1.30

0.96

1.2

1.3

25.7

24.2

0.11

199

(3002331) Protein [Mass/volume] in Peritoneal fluid

560

1.20

0.96

1.4

27.7

28.2

g/l

0.06

433

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.36

0.96

1.2

29.0

30.8

nmol/24h

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

303

1942

1.11

0.96

1.4

5.7

5.5

mmol/l

0.86

285

1837

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

423

2756

1.09

0.95

1.4

1.3

128.1

106.4

pmol/l

0.13

165

846

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

164

1.38

0.94

1.8

1.6

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.86

0.93

1.4

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.13

0.90

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1128

8390

0.95

0.90

1.4

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

271

1.28

0.89

1.1

—

(40763590) HLA-DQ beta [Type]

118

1.44

0.89

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

306

1973

1.10

0.88

1.3

644.5

494.9

u/l

0.57

285

1875

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.57

0.87

1.4

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

2.02

0.87

1.0

—

(3041184) Isoniazid [Presence] in Urine

1.83

0.86

2.6

2.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

126

771

1.16

0.86

1.3

1.4

59.4

61.6

0.30

102

639

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.70

0.86

1.1

1.0

—

(46236302) HLA-C [Type] by High resolution typing

119

1.43

0.86

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

180

1.34

0.84

1.3

1.1

—

(3022670) pH of Venous cord blood

1.65

0.83

1.0

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.65

0.83

1.0

1.3

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.77

0.83

1.1

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

622

4139

1.07

0.83

1.8

1.6

—

(3047189) Immunofixation for 24 hour Urine

175

1099

1.13

0.83

2.1

1.9

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

187

1.33

0.82

1.3

22.3

22.2

mmol/l

0.03

128

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.60

0.82

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.77

0.81

1.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

194

1.32

0.80

1.0

1.1

0.5

10.6

u/ml

0.49

(3015183) Erythrocyte sedimentation rate

289

1871

1.09

0.79

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

334

1.23

0.78

1.1

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

431

1.20

0.77

1.1

1.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

196

1.30

0.76

1.2

1.1

10.0

10.2

mg/l

0.04

179

(3033799) Differential panel - Peritoneal fluid

128

794

1.14

0.75

2.0

1.9

—

(40758292) HTLV I+II Ab panel - Serum

550

1.17

0.75

1.4

—

(40768795) Lymph node Pathology biopsy report

391

2982

0.93

0.75

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

267

1.25

0.72

1.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

173

1.31

0.72

1.0

0.2

9.0

u/ml

0.52

(40760410) HLA-B [Type] by High resolution

118

1.38

0.71

1.0

—

(40760409) HLA-A [Type] by High resolution

118

1.38

0.71

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

314

1.22

0.69

1.6

—

(3022689) Creatine [Moles/volume] in Urine

134

844

1.13

0.65

1.4

1.5

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

1.77

0.65

1.0

0.0

0.1

u/ml

—

(3051101) Glucose [Moles/volume] in Cord blood

421

0.82

0.64

4.6

5.7

—

(3018291) Platelet Ab [Presence] in Serum

1.59

0.64

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

592

1.15

0.64

2.1

1.8

1.6

3.6

ug/l

1.44

360

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

304

1.21

0.64

3.1

3.0

1.1

1.3

mg/l

0.43

194

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

732

4943

1.05

0.64

1.4

7.1

7.0

mmol/l

0.63

527

3562

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

183

1.28

0.64

6.0

5.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

202

1.26

0.63

4.7

4.9

—

(3013862) HLA-DP [Type]

121

1.35

0.63

1.0

—

(3020650) Glucose [Presence] in Urine

118

942

0.89

0.62

1.6

1.4

—

(3006598) pH of Arterial cord blood

1.48

0.62

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

310

2043

1.08

0.61

1.6

1.5

—

(3035880) pH of Pleural fluid

185

1193

1.10

0.60

1.2

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

147

937

1.11

0.60

2.4

2.0

607.1

3038.0

e6/l

1.50

102

628

(4133840)

124

984

0.89

0.60

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

141

1.31

0.59

1.0

1.2

—

(3034614) HLA Ag [Interpretation]

1.42

0.58

1.7

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

545

4066

0.95

0.58

3.2

3.1

0.8

nmol/l

0.83

404

3134

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

130

826

1.12

0.57

2.3

1.8

4086.0

12668.9

e6/l

1.93

428

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.56

0.56

2.6

2.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

420

0.84

0.55

1.7

6.5

7.4

mmol/l

1.01

127

(3041918) Cholesterol [Moles/volume] in Pleural fluid

416

1.16

0.54

1.2

1.7

1.8

mmol/l

0.07

243

(3023383) Lactate [Moles/volume] in Pleural fluid

103

650

1.12

0.52

1.3

3.6

3.5

mmol/l

0.16

602

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

208

1.23

0.52

1.1

6.7

18.3

iu/ml

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.52

0.52

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

438

1.15

0.51

1.4

1.3

—

(40762814) Titanium [Mass/volume] in Blood

422

0.86

0.48

2.0

2.4

4.3

3.8

ug/l

0.16

151

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

495

3350

1.05

0.46

1.6

7.9

7.5

mmol/l

2.35

301

1977

(3003434) Protein [Mass/volume] in Pleural fluid

431

2907

1.05

0.45

1.5

1.4

34.3

33.6

g/l

0.52

388

2644

(3028308) Erythrocytes [#/volume] in Pleural fluid

356

2389

1.06

0.45

1.5

1.4

49836.1

49260.9

e6/l

0.01

234

1390

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

109

0.72

0.45

1.2

—

(21494434) Karyotype in Bone marrow

324

2169

1.06

0.45

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

148

1.24

0.44

1.0

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

278

1.17

0.44

1.3

32.7

203.2

u/l

0.91

202

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.69

0.44

1.2

1.0

—

(3012441) Differential panel - Pleural fluid

339

2275

1.06

0.44

1.5

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.42

0.42

1.1

—

(40765096) Chromosome analysis panel by Banding

116

749

1.10

0.42

1.1

1.2

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.54

0.42

1.6

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

196

1.19

0.40

1.2

111.0

102.9

ug/l

0.11

124

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.35

0.40

1.1

1.2

21.8

29.5

mg/l

1.22

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.37

0.39

2.3

2.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

192

0.81

0.39

1.1

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

100

649

1.09

0.35

1.7

1.4

12.5

13.4

g/l

0.36

499

(4281824)

453

3334

0.96

0.34

1.2

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

109

1.24

0.32

1.0

0.0

0.2

u/ml

0.97

(3046861) Legionella sp Ag [Presence] in Urine

135

1.21

0.32

1.2

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

231

1553

1.05

0.32

1.2

1.3

13.1

14.4

u/l

0.58

210

1434

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

182

1.17

0.31

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

451

1.10

0.30

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

574

0.91

0.30

1.2

1.3

63.2

354.1

ug/l

2.83

311

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.27

0.30

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.32

0.30

1.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.34

0.29

1.0

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

447

1.09

0.28

3.0

2.8

2883.9

1533.7

u/l

0.66

408

(44806420)

620

1.07

0.26

2.0

2.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1567

10930

1.02

0.25

1.5

1.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

328

1.10

0.24

1.3

1.4

8.5

13.7

1.11

168

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

317

2168

1.04

0.24

1.3

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

113

756

1.06

0.22

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

306

0.90

0.22

1.6

1.5

112.8

116.4

ug/l

0.07

249

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

5.6

—

(3025311) HLA-B [Type]

0.00

0.22

0.0

1.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

175

1.13

0.21

2.1

2.3

16.6

17.1

0.02

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.4

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(4038314)

319

0.91

0.20

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.80

0.20

5.2

6.9

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

656

1.06

0.20

1.3

1.4

3.0

2.9

0.05

558

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.17

0.18

1.1

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

897

6260

1.02

0.17

4.1

3.1

22.1

26.5

mg/l

3.13

549

3869

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

221

1.09

0.15

2.1

2.3

40.5

61.1

2.16

134

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

443

0.94

0.14

6.4

7.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

623

1.05

0.14

2.5

2.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.81

0.14

1.3

1.1

—

(3025315) Body weight

257

1.08

0.13

4.2

4.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

127

1.12

0.13

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

203

1.08

0.12

4.7

2.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

286

1.07

0.12

1.2

1.3

5.4

6.2

mmol/l

0.50

143

(3044007) Cell count panel - Peritoneal fluid

110

752

1.04

0.12

2.3

1.9

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

397

1.05

0.12

8.6

8.9

0.4

umol/l

0.01

360

(3035611) Eosinophils/100 leukocytes in Synovial fluid

178

0.92

0.11

1.7

0.7

0.6

0.13

133

(3038071) Oxygen [Partial pressure] in Mixed venous blood

605

0.96

0.11

12.3

8.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

148

0.91

0.10

1.0

—

(3048879) Bone marrow aspiration report

103

707

1.03

0.09

2.2

1.9

—

(3011544) Albumin [Mass/volume] in Pleural fluid

199

1.07

0.09

1.1

1.2

19.0

17.4

g/l

0.63

179

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

144

1.08

0.09

1.2

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

117

0.91

0.08

1.0

0.0

1.0

u/ml

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.10

0.08

1.0

1.1

602.9

2090.7

titre

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.10

0.08

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

440

3083

1.01

0.07

1.4

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

159

1.07

0.07

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

684

0.97

0.07

11.8

8.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

107

740

1.02

0.07

1.4

1.2

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

125

1.08

0.06

1.1

1.0

0.1

0.5

u/ml

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.11

0.06

1.4

4.5

6.1

mg/l

0.14

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

324

0.96

0.06

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

419

1.03

0.06

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

135

0.94

0.04

1.0

0.2

0.3

u/ml

0.10

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

125

873

1.01

0.04

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

535

1.02

0.04

1.4

25.2

24.1

0.11

452

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

388

1.02

0.03

3.0

3.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

325

2317

0.99

0.03

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

136

1.04

0.02

30.0

13.1

—

(40758358) Immune stain study

133

0.96

0.02

1.0

—

(3001729) Color of Synovial fluid

211

0.97

0.01

1.6

—

(3003577) Lead [Moles/volume] in Blood

267

0.98

0.01

1.2

1.5

0.2

umol/l

0.25

(40768806) Pleura Pathology biopsy report

320

2273

1.00

0.00

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2850

20188

1.00

0.00

1.7

1.6

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

265

1.02

0.00

1.3

1.4

67.6

71.2

0.25

226

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

143

0.99

0.00

1.1

—

(4212803)

224

1.01

0.00

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

105

743

1.00

0.00

1.3

40.4

40.1

0.03

512

(3045142) Bone marrow Pathology biopsy report

409

2901

1.00

0.00

1.3

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.05

0.00

4.7

5.6

0.2

mmol/l

0.13

(3014891) Appearance of Pleural fluid

280

1.01

0.00

2.1

1.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.00

0.00

1.0

1.1

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.6

—

4.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.99

0.00

1.5

1.3

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.96

0.00

1.2

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.99

0.00

1.5

1.3

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.98

0.00

1.2

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

1.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_ANXIETY – Anxiety disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Anxiety disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Anxiety disorders (KRA_PSY_ANXIETY)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints